Mobius Social Stock Investment Simulation Competition Officially Launches, Registration Now Opens ACN Newswire

Mobius Social Stock Investment Simulation Competition Officially Launches, Registration Now Opens

Singapore, August 28, 2026 - (ACN Newswire via SeaPRwire.com) - The stock investment simulation competition, exclusively sponsored by Mobius Social, officially kicked off today in Singapore. Open to investors aged 18 and above in Singapore, the three-month competition runs from August 28 to November 28 and is expected to attract more than 30,000 participants. To encourage rational investing and scientific strategy, the competition has established a total prize pool of SGD 350,000, with top-performing participants invited to attend an offline awards ceremony in Singapore.Scientific Risk Control, Replicating Real Market DynamicsThe competition adopts a real-market simulation trading format, with each participant receiving USD 100,000 in virtual initial capital. To promote scientific asset allocation and prevent all-in, gambling-style trading, the competition has implemented a dual risk control mechanism:- Holdings in any single stock must not exceed 30% of total assets.- A 40% maximum drawdown risk control threshold is set; breaching this limit will trigger risk control intervention.The event organizers stated: “Through institutional design, we aim to guide investors toward establishing long-term, rational trading habits rather than pursuing short-term windfalls. The 40% drawdown threshold and 30% single-position limit are precisely intended to simulate the risk control standards of professional institutions.”Competition Schedule and Participation RulesThe three-month schedule will cover various market environments, providing a complete testing period for different investment strategies. Participants must complete no fewer than five valid trades throughout the competition and timely assess their positions and risks in response to market changes. Additionally, the “Simulation Analysis Sprint Period” scheduled from September 7 to September 18 will serve as a special challenge segment. During this phase, participants can focus on validating short-term strategies, and performance in this period will be one of the weighted factors in final ranking calculations.Participants can complete registration via the official Mobius website and join the official WhatsApp community to receive competition announcements, dynamic updates, and official support in real time. Registration remains open; please refer to the official website for the specific deadline.Launch Day Highlights: Offline Investment Exchange Summit Held SimultaneouslyOn the competition launch day, the organizers simultaneously held an offline investment exchange summit in Singapore, attracting hundreds of investors. Multiple senior experts in the investment field were present to deliver in-depth presentations on core topics including market trend analysis, stock valuation, technical trading system development, capital flow research, real-world case studies, and risk management systems. Attendees not only gained opportunities for face-to-face exchanges with experts but also gained deeper insight into the thinking frameworks and decision-making logic of institutional investors.Empowering Investors: The Long-Term Value of Mobius SocialAs the exclusive sponsor of this competition, Mobius Social is an app that integrates global major stock market data with investment-focused social networking features. The platform provides users with global market information and market exchange services, helping investors understand global market dynamics in a one-stop manner without frequently switching platforms, and share views and experiences with other investors and industry authorities.The Mobius Social Competition Committee stated: “Through the combination of ‘high-value prize incentives + realistic simulation exercises + strict risk control mechanisms + community exchange,’ we hope to provide a practical platform for investors of different experience levels, helping participants establish systematic investment decision-making processes, enhance risk awareness, and improve real-world capabilities. This is not just a competition; it is a collective evolution of investment capabilities.”For competition details, complete rules, and follow-up event arrangements, please follow the official Mobius website and official WhatsApp community.Risk Disclaimer: This competition is a simulation trading activity and does not involve real securities trading. Simulation trading results do not represent actual investment performance, and related content does not constitute investment advice. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Deepening Implementation of Technological Innovation, Accelerating Transformation of Productive Forces ACN Newswire

Deepening Implementation of Technological Innovation, Accelerating Transformation of Productive Forces

HONG KONG, August 28, 2026 - (ACN Newswire via SeaPRwire.com) - Legend Holdings Corporation (“Legend Holdings” or the “Company”; Stock Code: 3396.HK) announced the unaudited condensed consolidated interim results for the six months ended June 30, 2026 (the “Reporting Period”). During the Reporting Period, the Company recorded revenue of RMB362.935 billion, representing a 29% year-on-year increase, primarily driven by the significant revenue growth of its subsidiaries Lenovo and Levima Advanced Materials; net profit attributable to equity holders of the Company was RMB2.230 billion, up 219% year-on-year, driven by the recovery in portfolio value of the industrial incubations and investments segment. Excluding the impact of a one-off item, net profit attributable to equity holders of Legend Holdings was RMB5.812 billion, a year-on-year increase of 834%.In the first half of 2026, Legend Holdings remained committed to technological innovation as the key driver for high-quality development and continued to enhance its distinctive technological innovation system. The Company actively drove the coordinated advancement of “anchoring diversified-industries operations in technology-focused core businesses, extending ecosystem coverage through technology innovation funds, and driving the very early-stage industrialization of forward-looking technologies.” This expedited the transformation from scientific and technological achievements into real productive forces, and drove a steady improvement in the Company's core competitiveness, with significant performance growth, laying a solid foundation for the Company’s sustainable development.RMB 10 Billion in R&D Investment, Together with a Solidified Technology FoundationDuring the Reporting Period, Legend Holdings’ total R&D investment exceeded RMB10 billion, a historical record high for its midyear report. Its portfolio companies continued to deliver steady growth with solid fundamentals. Lenovo capitalized on the surge in hybrid AI, with all three major business segments delivering double-digit revenue growth and reaching record highs for the same period. AI has become Lenovo’s core growth engine, with AI-related revenue increasing by 64% for the same period and accounted for 36% of Lenovo’s total revenue. Levima Advanced Materials posted significant performance growth and made breakthroughs in a number of major projects. Among them, the m-Xylylene Diisocyanate (XDI) project was listed under the National Key R&D Program. Built on Levima’s technical expertise and R&D experience, the PEEK project has entered the construction phase. Both projects are expected to be completed and put into operation in 2027, filling domestic technology gaps.Technology Ecosystem Bearing Fruit, and 12 Portfolio Companies Successfully ListedLeveraging years of dedicated efforts in technology innovation, Legend Holdings has cultivated a robust ecosystem spanning emerging and future industries. This ecosystem is now delivering tangible returns, not only driving significant performance growth for the Company, but also accumulating momentum for long-term development. During the Reporting Period, the industrial incubations and investments segment’s depth of technology asset pipeline and ability to realize value from these assets both improved. In the first half of 2026, the Legend Holdings Family Group supported the listing of 12 portfolio companies. These listed companies spanned sectors including artificial intelligence, semiconductors, advanced manufacturing, and healthcare. More than 30 additional portfolio companies are currently in the pre-listing pipeline. The Company invested in over 80 technology projects in the first half of the year across frontier fields such as artificial intelligence, quantum computing, optical interconnects, embodied artificial intelligence, chips and semiconductors, biopharmaceuticals, and commercial aerospace. To date, Legend Holdings has invested in over 300 AI-related companies. The Company has also established a systematic presence in other frontier fields, having invested in over 110 companies in pharmaceuticals and healthcare, over 60 companies in sustainable industries and future energy, and more than 50 companies in embodied artificial intelligence.Fostering Industry-Academia-Research Collaborative Innovation and Exploring New Pathways for Commercializing Original TechnologiesResponding to the call to “accelerate the translation from technological advances into productive forces”, Legend Holdings leverages its Forward-Looking Technology Research Institute to actively promote industry-academia-research collaborative innovation and explore new pathways for the commercialization of pioneering technologies. In the first half of the year, Legend Holdings established the Advanced Photonic Integration Joint Laboratory with a National Key Laboratory at Peking University. Together with the research team, the Company published co-authored papers and filed joint patents, while making preparations to establish a dedicated operating entity. In addition, led by the Chinese Information Processing Society of China (CIPS), and jointly initiated by Legend Holdings and other organizations, the Industry University Research Working Committee of the Chinese Information Processing Society of China was established, focusing on frontier areas of artificial intelligence. The Committee translates real-world industry needs into concrete workstreams. The Company has built a “Covalent Innovation” model that brings real-world industry needs into the earliest stages of R&D, enabling businesses and researchers to jointly set priorities and develop solutions. It aims to create a replicable pathway for translating more creative innovation into new quality productive forces.ESG Practices Gaining Authoritative Recognition, Corporate Responsibility Underpinning the Foundation for SustainabilityLegend Holdings prioritizes ecological conservation and green development. Lenovo has repeatedly received authoritative recognition both domestically and internationally in the ESG field. It has retained the highest global 3A rating in the MSCI ESG Ratings and received the EcoVadis Platinum Medal, its highest distinction, for two consecutive years. It was also included in the Fortune China ESG Impact List for five consecutive years. Its green operations continued to deliver strong results: over 90% of the electricity used in Lenovo’s global operations came from renewable energy sources. More than 360 million kilograms of end-of-life products have been recovered and reused. In photovoltaic materials, Levima Advanced Materials operates two major product lines for photovoltaic adhesive film materials, EVA and POE, with an annual production capacity exceeding 350,000 tons. In new energy battery materials, the company has built a comprehensive portfolio. In green investment, Legend Holdings has invested in more than 60 companies across new energy, energy decarbonization and so on. The Legend Star CEO Training Program has been running for over 18 years, nurturing up to 1,429 startup founders with 77 listed companies, 217 national-level specialized and innovative “Little Giant” enterprises, 930 High-and New-Technology Enterprises (HNTE), and more than 460,000 jobs created.Looking ahead, Legend Holdings will continue to closely align with national strategic needs, adhere to the main thread of technological innovation driving high-quality development, steadily improve its distinctive technological innovation system, deepen its focus on technology as its core business, and accelerate the promotion of the transformation of scientific achievements into real productive forces, making unremitting contributions to Chinese modernization and self-reliance and strength in science and technology. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Cryofocus Announces 2026 Interim Results: Loss Narrows 37.9% to RMB 16.9 Million, Gross Margin Improves to 68.5% ACN Newswire

Cryofocus Announces 2026 Interim Results: Loss Narrows 37.9% to RMB 16.9 Million, Gross Margin Improves to 68.5%

HONG KONG, August 28, 2026 - (ACN Newswire via SeaPRwire.com) - Cryofocus Medtech (Shanghai) Co., Ltd. (“Cryofocus” or the “Company,” stock code: 6922.HK), a leading innovative medical device platform specializing in minimally-invasive interventional cryotherapy, today announced its interim results for the six months ended June 30, 2026. During the Reporting Period, the Company continued to expand its product pipeline, with a significant 37.9% narrowing of its loss for the period to RMB 16.9 million. Gross profit margin improved to 68.5% from 67.1% in the same period last year, while cash and cash equivalents surged 69.2% to RMB 59.3 million compared to the end of 2025, underscoring enhanced operational quality and financial resilience.Product Pipeline Continues to Expand, Commercial Footprint WidensAs a pioneer in the field of minimally-invasive interventional cryotherapy in China, Cryofocus has established a comprehensive product portfolio covering both vascular intervention and natural orifice transluminal endoscopic surgery (NOTES). As of June 30, 2026, the Company had a total of 25 products and product candidates, of which 11 had been commercialized. These include the Atrial Fibrillation Cryoablation System, Malignant Stenosis Cryoablation System, Cryoadhesion System, Bladder Cryoablation System, and Pulmonary Nodule Localization Needle, among others.In January 2026, the Company’s Endoscopic Additional Working Channel Catheter received approval from the Zhejiang Medical Products Administration, further enriching its commercial product matrix. Meanwhile, several high-value product candidates have entered the critical confirmatory clinical trial stage and are expected to receive approvals sequentially between 2027 and 2029. These include:- Vascular Intervention:Cryofocus Renal Denervation System (Cryo-RDN System): Designed to be the world’s first cryoablation product specifically targeting hypertension. It was granted Breakthrough Device designation by the U.S. FDA in December 2022.- Respiratory Intervention:COPD Cryospray System, Peri-Pulmonary Nodule Cryoablation System, Asthma Cryoablation System, and Benign Stenosis Cryoablation System: These products form a matrix of investigational devices targeting the same hospital department. As they receive approvals in the coming period, the synergistic effect of this product matrix is expected to amplify.The Company’s R&D team comprises 40 professionals. As of June 30, 2026, Cryofocus held 179 patents and 35 patent applications domestically and internationally, continuously deepening its technological moat.Loss Narrows Significantly, Gross Margin Improves Against HeadwindsAlongside steady progress in its product pipeline, the Company delivered impressive financial metrics. For the first half of 2026, Cryofocus recorded revenue of RMB 40.7 million and gross profit of RMB 27.9 million. The loss for the period amounted to RMB 16.9 million, a decrease of RMB 10.3 million or 37.9% from RMB 27.2 million in the same period of 2025.Against the backdrop of an active adjustment in revenue scale, the Company’s overall gross profit margin rose from 67.1% to 68.5%, primarily driven by process improvements and optimizations for certain products. This indicates that structural improvements in the product mix and enhanced production efficiency have effectively offset the impact of revenue fluctuations on profitability.Comprehensive Cost Optimization Boosts Operating Efficiency Significantly The substantial narrowing of losses was underpinned by the Company’s holistic cost control measures:- Administrative expenses decreased by 34.0% from RMB 33.7 million to RMB 22.3 million, mainly due to reductions in staff costs and share-based payments.- Selling and distribution expenses fell by 14.5% from RMB 9.2 million to RMB 7.8 million.- Research and development expenses declined by 15.1% from RMB 17.9 million to RMB 15.2 million.- Finance costs dropped by 22.7% from RMB 1.1 million to RMB 0.8 million.Furthermore, other income and gains surged over 550% from RMB 0.5 million to RMB 3.2 million, primarily attributable to an increase in government grants. The combined effect of comprehensive cost optimization and growth in non-recurring income enabled the Company to achieve a sharp compression of losses despite a temporary decline in revenue.Cash Reserves Surge 69.2%, Strengthening Capital PositionAs of June 30, 2026, the Company’s cash and cash equivalents stood at RMB 59.3 million, an increase of RMB 24.2 million or 69.2% from RMB 35.0 million as of December 31, 2025. This growth was mainly driven by the completion of an H-share placing in January 2026, under which the Company issued 5,595,000 H-shares and raised net proceeds of approximately HK$29.73 million.Additionally, the Company’s current ratio improved from 1.5 to 1.7, the quick ratio rose from 1.0 to 1.2, and the gearing ratio decreased from 64.7% to 61.8%, reflecting enhanced short-term solvency and overall financial safety.Outlook: Committed to Becoming a Global Minimally-Invasive Interventional Cryotherapy Medical Device Platform, Bringing Benefits to Patients and Physicians WorldwideIn the first half of 2026, the Company proactively adjusted its sales strategy to align with evolving industry demands, leading to a temporary dip in revenue. However, earnings quality improved markedly, signaling a positive trend of “structural revenue adjustment with clear profit elasticity.”Looking ahead, the Company will:- Rapidly advance the clinical development and commercialization of its product candidates based on cryotherapy technology;- Continue to focus on minimally-invasive interventional cryotherapy and further expand its product portfolio leveraging its technology platform;- Persistently research and develop various underlying and supporting technologies; and- Selectively expand its global footprint.With high-value products such as the Cryofocus Renal Denervation System, COPD Cryospray System, and Peri-Pulmonary Nodule Cryoablation System entering the regulatory submission and launch cycle, coupled with a significantly strengthened cash position and continuous loss reduction, Cryofocus is steadily accelerating toward its vision of becoming a “global minimally-invasive interventional cryotherapy medical device platform.” Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Analogue Announces 2026 Interim Results ACN Newswire

Analogue Announces 2026 Interim Results

HONG KONG, August 28, 2026 - (ACN Newswire via SeaPRwire.com) - Analogue Holdings Limited (“Analogue” or the “Company”, together with its subsidiaries, the “Group”) (stock code: 1977), a leading provider of electrical and mechanical (“E&M”) engineering solutions, and information and communications technology services for smart cities, today announced its interim results for the six months ended 30 June 2026 (the “Period”) with interim contracts-in-hand continuing their record-setting performance, providing a solid foundation for the business over the next three years and beyond.Business Highlights- Interim contracts-in-hand surged by 34.9% to HK$17,649.3 million, attaining yet another record high- Revenue was HK$3,036.6 million, up by 5.7%, primarily driven by steady project execution in the Building Services and Environmental Engineering segments- Profit attributable to owners of the Company increased 88.1% to HK$152.0 million. The increase was partly attributable to the disposal of an approximately 3% equity stake in Nanjing Canatal Data-Centre Environmental Tech Co., Ltd.(Shanghai Stock Code: 603912)- The Group maintained a strong cash position, with bank balances and cash at HK$1,214.1 million- Interim dividend amounted to HK4.9 cents per share, with a year-on-year increase of more than 88%- Artificial Intelligence (AI) has been integrated into Analogue’s interconnected smart ecosystem to create value for customers, by realising a smart platform for buildings, and advanced operational solutions for water and sewage treatment, as evidenced by the prestigious accolades across both the research and adoption categories at the inaugural Construction Industry Council AI Award 2026 and at the ASHRAE Region XIII Technology Award 2026Chairman Dr Mak Kin Wah said, “Building on our outstanding achievement of record-high contracts-in-hand in 2025, the Group maintained steady business performance in the first half of 2026. By integrating research, development and application of AI technologies, we have achieved optimised operations and enhanced quality that earn wide recognition from the industry. Committed to innovation, the Group will further promote integration of AI, Digital Twin, and the Internet of Things (“IoT”), develop cross-technology integrated solutions, and enhance performance in engineering operations, safety, and sustainable development, to create greater value for clients.”“Our commitment to business ethics, quality, safety, health and environmental sustainability remains at the core of everything we do, guiding our decisions, shaping our culture, and contributing to a more sustainable future."Business Review: Building Services- This segment remains the largest revenue contributor, with revenue reaching HK$1,649.6 million.- Interim contracts-in-hand reached a record-high level of HK$7,996.6 million, with order intake standing at HK$1,348.8 million and many of the tenders submitted in the Period due for determination in phases later this year.- Many projects in the Northern Metropolis, including Fanling and Kwu Tung housing projects and various hospitals, were prioritised for commencement and progress in execution.- The Group’s expertise in Building Information Modelling (BIM), Design for Manufacture and Assembly (DfMA) and Modular Integrated Mechanical, Electrical and Plumbing (MiMEP) continued to gain market traction and helped secure major contracts.- Leveraging our comprehensive interdisciplinary capacity and new engineering techniques, this segment maintained our industry leadership, and was broadening our market reach to different parts of Asia.Environmental Engineering- This segment achieved record-high interim contracts-in-hand, which surged substantially by 78.3% year-on-year to HK$8,164.2 million. Order intake stood at HK$910.1 million with active ongoing tendering activities and many of the tenders submitted in the period due for determination in phases later this year. Segment revenue increased by 17.2% year-on-year or HK$123.2 million.- A number of projects, including a landmark engineering contract to reprovision critical sewage treatment works to caverns, were prioritised for commencement and execution.- New term contracts for sewage and E&M systems were also added to the recurrent operation, maintenance, and facility management services provided by the segment.- By deploying AI and Digital Twin under our industry-recognised AlgoWater® brand, the segment continued to strengthen our industry leading position by advancing in intelligent automation, predictive asset management, and real-time process optimisation that significantly enhance treatment efficiency and energy savings for industrial operations.- Continued to pursue project opportunities with partners in the Chinese Mainland and different parts in Asia and Europe.Information, Communications and Building Technologies (“ICBT”)- Segment revenue amounted to HK$290.9 million. Contracts-in-hand totalled HK$830.8 million. Order intake was HK$269.9 million.- As an early mover backed by its own R&D capability and extensive project experience, this segment was well positioned to continue to advance innovation. A robust digital foundation was established through the Digital Plant and Centralised Management Platform (CMP) that enables real-time insights and data-driven decisions.- Integration of IoT and advanced Building Management System (BMS) under our acclaimed DigiFusion® AI Smart Building Platform delivers optimised operational efficiency and enhanced tenant experiences in smart buildings and city infrastructure, as well as resource circularity for our clients.Lifts and Escalators- Revenue and contracts-in-hand were at HK$255.9 million and HK$657.7 million respectively.- Order intake totalled HK$278.4 million, with ongoing tendering activities in different parts of the world.- Transel Elevator & Electric Inc. (TEI), the associate company in the United States, maintained its strength as one of the largest independent lift and escalator companies in New York and continued to expand in the southeastern part of the country, strengthening our market positioning and future growth.- Competitiveness was strengthened with enhanced automation in production lines and strict quality controls, to anchor the end-to-end business model from design, through manufacturing, to installation and maintenance services.- The product portfolio was broadened in line with the expanding international market reach and enhanced with next-generation product innovations.For further details of the 2026 Interim Results, please refer to the announcement filed with The Stock Exchange of Hong Kong Limited.About Analogue Holdings LimitedEstablished in 1977, Analogue Holdings Limited is a leading provider of electrical and mechanical (“E&M”) engineering solutions and information and communications technology (“ICT”) services for smart cities, with headquarters in Hong Kong and operations in the Chinese Mainland, Macau, the United States, the United Kingdom, Germany, Singapore and Malaysia. Serving a wide spectrum of customers from public and private sectors, the Group provides multidisciplinary and comprehensive E&M engineering and technology services in four major segments, including Building Services, Environmental Engineering, Information, Communications and Building Technologies (“ICBT”) and Lifts & Escalators.The Group also manufactures and sells lifts and escalators internationally and has entered into an alliance with Transel Elevator & Electric Inc. (“TEI”), one of the largest independent lifts and escalators companies in New York, the United States. The Group’s associate partner, Nanjing Canatal Data-Centre Environmental Tech Co., Ltd. (Shanghai Stock Code: 603912), specialises in precision environmental control technologies and related energy-saving and temperature control equipment for data centres. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
COSCO SHIPPING Ports Announces 2026 Interim Results ACN Newswire

COSCO SHIPPING Ports Announces 2026 Interim Results

HONG KONG, August 28, 2026 - (ACN Newswire via SeaPRwire.com) - COSCO SHIPPING Ports Limited (“COSCO SHIPPING Ports” or “CSP” or the “Company”, SEHK: 1199), the world’s leading ports logistics service provider, today announced the interim results of the Company and its subsidiaries (the “Group”) for the 6 months ended 30 June 2026.2026 Interim Results Highlights- Total throughput increased by 7.9% YoY to 80,157,047 TEU- Equity throughput increased by 7.0% YoY to 24,492,008 TEU- Revenue of the Company increased by 12.3% YoY to US$905,344,000- Gross profit increased by 9.3% YoY to US$239,507,000- Profit attributable to equity holders of the Company increased by 28.5% YoY to US$233,672,000- Declared a first interim dividend of US2.360 cents per shareFINANCIAL REVIEWIn the first half of 2026, the global shipping market was under dual pressure from route network restructuring and compressed profitability. In the face of these challenges, COSCO SHIPPING Ports has sustained its overall operational resilience by continued deepening of its lean operation management and constant optimisation of its resource allocation and business processes. In the first half of 2026, revenue of the Company increased by 12.3% YoY to US$905.3 million; gross profit increased by 9.3% YoY to US$239.5 million. During the period, the profit attributable to equity holders of the Company greatly increased by 28.5% YoY to US$233.7 million.OPERATIONAL REVIEWOverall PerformanceFor the six months ended 30 June 2026, the Group’s total throughput increased by 7.9% YoY to 80,157,047 TEU (1H2025: 74,295,971 TEU). Total throughput from terminals in which the Group has controlling stake increased by 2.5% YoY to 16,893,574 TEU (1H2025: 16,482,018 TEU), accounting for 21.1% of the Group’s total, and the total throughput from non-controlling terminals increased by 9.4% YoY to 63,263,473 TEU (1H2025: 57,813,953 TEU), accounting for 78.9% of the Group’s total.During the period, the Group’s total equity throughput increased by 7.0% YoY to 24,492,008 TEU (1H2025: 22,879,575 TEU). The equity throughput from terminals in which the Group has controlling stake increased by 2.6% YoY to 9,941,962 TEU (1H2025: 9,691,543 TEU), accounting for 40.6% of the Group’s total, and the equity throughput from non-controlling terminals increased by 10.3% YoY to 14,550,046 TEU (1H2025: 13,188,032 TEU), accounting for 59.4% of the Group’s total.ChinaDuring the period, total throughput of the terminals in China increased by 4.7% YoY to 59,019,217 TEU (1H2025: 56,390,125 TEU) and accounted for 73.6% of the Group’s total throughput. Total equity throughput of terminals in China increased by 4.8% YoY to 16,915,369 TEU (1H2025: 16,136,373 TEU), accounting for 69.1% of the Group’s total equity throughput.Bohai RimDuring the period, total throughput of the Bohai Rim region increased by 6.4% YoY to 27,483,548 TEU (1H2025: 25,835,742 TEU) and accounted for 34.3% of the Group’s total throughput. Total equity throughput of the Bohai Rim region increased by 6.0% YoY to 6,989,982 TEU (1H2025: 6,594,957 TEU) and accounted for 28.5% of the Group’s total equity throughput. Driven by the increasing investment demand in artificial intelligence, exports of high-tech products recorded steady growth, contributing a 4.8% YoY increase in the total throughput of Dalian Container Terminal Co., Ltd. to 2,695,849 TEU (1H2025: 2,572,124 TEU).Yangtze River DeltaDuring the period, total throughput of the Yangtze River Delta region increased by 3.6% YoY to 8,684,169 TEU (1H2025: 8,379,156 TEU) and accounted for 10.8% of the Group’s total throughput. Total equity throughput of the Yangtze River Delta region increased by 6.2% YoY to 2,558,738 TEU (1H2025: 2,408,543 TEU) and accounted for 10.5% of the Group’s total equity throughput. Wuhan CSP Terminal Co., Ltd. (“CSP Wuhan Terminal”) continued to reinforce its competitive edge as a rail-water intermodal transport hub while expanding its Yangtze River feeder network, driving a 34.6% YoY increase in total throughput to 198,577 TEU (1H2025: 147,515 TEU).Southeast Coast and OthersDuring the period, total throughput in the Southeast Coast and Others region decreased by 2.8% YoY to 2,704,696 TEU (1H2025: 2,783,306 TEU) and accounted for 3.4% of the Group’s total throughput. Total equity throughput of Southeast Coast and Others region increased by 3.0% YoY to 2,131,636 TEU (1H2025: 2,070,554 TEU) and accounted for 8.7% of the Group’s total equity throughput. Xiamen Ocean Gate Container Terminal Co., Ltd. continued to strengthen its terminal hub capability, and through the introduction of new route services in the first half of the year, the total throughput increased by 6.8% YoY to 1,366,387 TEU (1H2025: 1,279,547 TEU).Pearl River DeltaDuring the period, total throughput of the Pearl River Delta region increased by 6.5% YoY to 15,577,680 TEU (1H2025: 14,633,421 TEU) and accounted for 19.4% of the Group’s total throughput. Total equity throughput of the Pearl River Delta region increased by 4.6% YoY to 4,237,042 TEU (1H2025: 4,052,292 TEU) and accounted for 17.3% of the Group’s total equity throughput. Driven by trade demand from emerging markets such as Southeast Asia, Guangzhou South China Oceangate Container Terminal Company Limited successfully introduced multiple new shipping routes, driving a 7.4% YoY increase in total throughput to 3,221,826 TEU (1H2025: 3,001,192 TEU).Southwest CoastDuring the period, total throughput of the Southwest Coast region decreased by 4.0% YoY to 4,569,124 TEU (1H2025: 4,758,500 TEU), accounting for 5.7% of the Group’s total throughput. Total equity throughput of the Southwest Coast region decreased by 1.2% YoY to 997,971 TEU (1H2025: 1,010,027 TEU) and accounted for 4.1% of the Group’s total equity throughput. Due to market volatility and changes in cargo mix, total throughput and equity throughput in the Southwest Coast region recorded a YoY decrease.OverseasDuring the period, total throughput in overseas terminals increased by 18.0% YoY to 21,137,830 TEU (1H2025: 17,905,846 TEU) and accounted for 26.4% of the Group’s total throughput. Total equity throughput in overseas terminals increased by 12.4% YoY to 7,576,639 TEU (1H2025: 6,743,202 TEU) and accounted for 30.9% of the Group’s total equity throughput. Piraeus Container Terminal Single Member S.A. (“Piraeus Terminal”) recorded a 2.9% YoY decrease in total throughput to 1,995,150 TEU (1H2025: 2,054,895 TEU), due to softening market demand in the Mediterranean region and adverse weather conditions. CSP Abu Dhabi Terminal L.L.C. (“CSP Abu Dhabi Terminal”) recorded a 44.3% YoY decrease in total throughput to 442,977 TEU (1H2025: 795,758 TEU), affected by geopolitical tensions in the Middle East. COSCO SHIPPING Ports Chancay PERU S.A. (“CSP Chancay Terminal”) has been actively advancing corridor development, deepening synergies with the parent Company’s dual-brand operations, and continuously enhancing its route network layout. In the first half of the year, the terminal achieved a route network of three main lines and five feeder lines, further strengthening its regional connectivity and driving a 68.2% YoY increase in total throughput to 201,773 TEU (1H2025: 119,945 TEU).PROSPECTSSince the beginning of 2026, amid continued deep adjustments to the global economic and trade landscape and rising geopolitical uncertainties, COSCO SHIPPING Ports has remained committed to high-quality development as its overarching priority. The Company has consistently strengthened its core hub layout and global network resilience, while fully leveraging synergies with COSCO SHIPPING Group and the Ocean Alliance. In the first half of the year, the Company’s total throughput and profit attributable to equity holders maintained a YoY increase, with steady improvements in operational quality and efficiency.Looking ahead, international institutions including the World Bank Group and the International Monetary Fund have successively downgraded their global economic growth forecasts. The World Bank projects that global economic growth will moderate from 2.9% in 2025 to 2.5% in 2026, while the IMF has revised its 2026 global growth forecast down to 3%, reflecting the impact of tensions in the Middle East. Changes in the global trade policy environment and fluctuations in energy prices have placed certain pressure on merchandise trade growth. Against this backdrop, the Chinese economy has demonstrated strong resilience. According to statistics from the General Administration of Customs of China, in the first half of the year, the total value of goods imports and exports reached RMB25.47 trillion, representing a YoY increase of 16.9%. Of this, exports amounted to RMB14.73 trillion, a YoY increase of 13.4%; imports totaled RMB10.74 trillion, a YoY increase of 22.1%. China’s trade with emerging markets such as ASEAN and Latin America has continued to deepen, while the share of high-value-added products, including electric vehicles, lithium batteries and photovoltaic products, has steadily increased. These developments have provided strong support for the development of the port industry.In the face of heightened external uncertainties, the Company will remain customer-centric and continue to optimise its global terminal network resource allocation. It will accelerate investment in emerging markets, regional markets and third-country markets, pursuing controlling stakes in strategic hubs while taking minority stakes in key gateway ports as market conditions permit. The Company will also enhance its main and feeder network layout to achieve interconnected and coordinated development across its terminals. It will accelerate the development of port-side logistics parks and supply chain extension services, building integrated resource synergies to provide customers with efficient and convenient port logistics supply chain solutions.Centred on its core port operations, the Company will continue to deepen lean operations and enhance its overall competitiveness. It will reinforce hub port development, raising the service capacity of key hubs including CSP Wuhan Terminal, Piraeus Terminal, CSP Abu Dhabi Terminal and CSP Chancay Terminal. In response to the evolving geopolitical situation in the Middle East, the Company will closely monitor developments, refine contingency plans and information-sharing mechanisms, and continue to optimise feeder network layouts and multi-modal logistics corridors to enhance supply chain resilience. This will enable it to provide more reliable port logistics services to regional customers and effectively address challenges arising from external changes. Under the new landscape of shipping alliances, the Company will strengthen its route network through targeted marketing, actively respond to market changes and route adjustments, continue to introduce new routes and secure additional calls. By improving service quality, it will reinforce its competitive advantage and sustain steady growth in its core business.In terms of green and low-carbon development, the Company will actively cultivate new quality productive forces in the port and shipping industry and lead the sector’s transformation and upgrading. It will continue to advance full-process automation at its terminals, deepen the application of AI and other technologies across all aspects of port operations, and accelerate digitalisation to enable data connectivity and collaborative synergy across systems. The Company will also extend its traditional cargo-handling business towards integrated logistics services, actively developing integrated “shipping + port + logistics” service offerings. With a focus on building green and low-carbon ports, it will further enhance its energy management platform, expand the use of clean energy, and actively participate in the green fuel supply chain to develop full-chain green and low-carbon products, setting industry benchmarks and building new advantages for sustainable development.About COSCO SHIPPING Ports (https://ports.coscoshipping.com)COSCO SHIPPING Ports Limited (Stock Code: 1199) is a leading ports logistics service provider in the world and its terminals portfolio covers the five main port regions and the middle and lower reaches of the Yangtze River in China, Europe, the Mediterranean, the Middle East, Southeast Asia, South America and Africa, etc. As at 30 June 2026, COSCO SHIPPING Ports operated and managed 394 berths at 40 ports globally, of which 245 were for containers.Building on the brand philosophy of “The Ports for ALL”, COSCO SHIPPING Ports has established its corporate mission of “Connecting Different Worlds” and is committed to maintaining a customer-centric approach to continuously improve the service and capacity of its global network and enhance the strategic positioning of key node ports and optimise logistics resource distribution. Leveraging ports as a conduit to connect global shipping services and serve global trade, the Company is dedicated to establishing a platform for mutual benefits and shared successes for all stakeholders involved with a vision of becoming “the leading global port logistics service provider with a customer-oriented focus”.Please visit the Company’s website (https://ports.coscoshipping.com) and the designated website of Hong Kong Exchanges and Clearing Limited (https://www.hkexnews.hk) for 2026 Interim Results Announcement. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More

Fosun International Delivers 160.3% YoY Profit Growth in 1H2026

HONG KONG, August 28, 2026 - (ACN Newswire via SeaPRwire.com) - On the evening of 27 August, Fosun International announced its 2026 interim results. During the Reporting Period, its total revenue reached RMB86.96 billion; profit attributable to owners of the parent reached RMB1.72 billion, representing a year-on-year increase of 160.3%; overseas revenue reached RMB49.16 billion, with its share of total revenue rising to 56.5%; total debt to total capital ratio decreased to 55.7%.These figures show that Fosun’s results fall in the upper-middle range of the Company’s profit alert (profit attributable to owners of the parent is expected to range from approximately RMB1.5 billion to RMB1.8 billion, representing a year-on-year increase of approximately 127% to 172%) issued on 29 July. This marks Fosun’s return to a growth trajectory following the completion of a systematic realignment of “repairing the roof on a sunny day”.Over the past few years, Fosun has taken a rather unconventional path. Since 2022, in response to the severe market disruption caused by the pandemic, the Company has advanced its business streamlining and core business-focused strategy, divesting assets and businesses and generating cumulative cash proceeds of approximately RMB75 billion. In March 2026, pursuant to the principle of prudence, Fosun made one-off, non-cash impairment provisions and value revaluations on certain real estate projects with impairment indicators and goodwill and intangible assets of certain non-core business segments. The move drew considerable market attention at the time. At the Company’s 2025 annual results presentation at the end of March, Guo Guangchang, Chairman of Fosun International, explained, “This is about ‘repairing the roof on a sunny day’, allowing Fosun to focus its resources and efforts more effectively on core, high-growth areas.”The market has now responded to Fosun’s “repairing the roof on a sunny day” initiative. From the announcement of profit alert in early March to 25 August, before its interim results announcement, Fosun’s share price rose sharply from HKD3.6 to HKD5.41, representing an increase of more than 50%. The market has gradually recognized and priced in the Group’s “risk clearance” efforts.More importantly, the earnings growth driven by the Group’s businesses has begun to materialize. At the 2026 interim results presentation held in Hong Kong on 28 August, Guo Guangchang said: “The strong results recovery we delivered in the first half of the year reflects the outcome of the strategic adjustments we have made over the past few years. Our ‘repairing the roof on a sunny day’ strategy has paid off, allowing us to put historical burdens behind us. These results mark the beginning of Fosun’s continued progress along a trajectory of steady growth.”Solid Core Businesses, with Pharmaceuticals and Insurance Posting Strong ResultsFirst, let us look at Fosun’s core businesses. In the first half of 2026, its four core businesses — Fosun Pharma, Yuyuan, Fosun Insurance Portugal (Fidelidade), and the Tourism segment — generated a total revenue of RMB63.88 billion, accounting for 73.5% of the Group’s total revenue, further demonstrating the results of its core business-focused strategy.Among them, the pharmaceutical and insurance segments delivered particularly strong performance.In the first half of the year, Fosun Pharma achieved operating revenue of RMB20.377 billion. Revenue from innovative drugs recorded a year-on-year increase of 13.84%, with their contribution to pharmaceutical business revenue rising to 33.35%, establishing innovative drugs as a key growth driver. Its innovative biopharmaceutical platform, Henlius, reported revenue of RMB3.5882 billion, representing a year-on-year increase of 27.3%, while net profit amounted to RMB430.4 million, up 10.3% year-on-year, sustaining growth momentum in revenue and profit. Commercialization of innovative drugs continued to gain traction. During the Reporting Period, Fosun Pharma had a total of 20 indications of 7 innovative drugs approved for launch both domestically and overseas. With their revenue share on a steady rise, innovative drugs have become the main growth engine driving the pharmaceutical business forward.The insurance segment delivered a stellar performance, with Fosun’s domestic and overseas insurance companies all posting broad-based improvements. Fidelidade’s overall market share in Portugal reached 30.1%, and its international business accounted for 26.7% of its consolidated total business. In the first half of the year, Fidelidade recorded net profit attributable to owners of the parent of EUR165 million, up 23.8% year-on-year, maintaining steady growth.In Chinese mainland, Pramerica Fosun Life Insurance recorded gross written premiums of RMB8.38 billion in the first half of 2026, up 52.2% year-on-year. Net profit reached RMB780 million, representing a year-on-year increase of 270% and exceeding its net profit for the full year of 2025. Fosun United Health Insurance reported a 36.2% year-on-year increase in revenue and net profit of RMB572 million. Peak Reinsurance’s reinsurance revenue and gross written premiums increased by 25% and 11.8% year-on- year, respectively, while net profit after tax reached USD89.70 million. In April 2026, Moody’s upgraded Peak Re’s rating from Baa1 to A3, with a “stable” outlook.Guo Guangchang said at the results presentation: “Integrating our insurance business with industries in which we have established competitive advantages has been a strategic priority for Fosun for over three decades — a critical linkage we have long sought to unlock. I believe we have now achieved it. This integration will significantly strengthen our industrial operational capabilities and future profitability, providing sustained momentum for Fosun’s development.”“Successfully navigating another cycle” is how the market has described Fosun’s latest round of adjustments. A closer look reveals how Fosun has successfully navigated the cycle. On the one hand, the Group has continued to streamline its business to generate cash proceeds. In the first half of the year, the Group generated proceeds equivalent to more than RMB12.0 billion from the divestment of non-strategic and non-core assets. Its total debt to total capital ratio was reduced to 55.7%, while its cash, bank balances and term deposits amounted to RMB61.214 billion. On the other hand, the innovation and globalization strategy that the Group has been pursuing for years has entered a value-realization phase, serving as the core engine driving profit recovery.Integrated Innovation Strategy Bears FruitSince innovative drugs took off in the domestic market in 2025, Fosun has repeatedly broken into the spotlight, with multiple innovative drug business development (BD) drawing significant market attention. In fact, as the saying goes, “One minute on stage takes ten years of hard work off stage”. This series of innovation achievements is the result of Fosun’s forward-looking innovation strategy established nearly two decades ago.Notably, for more than a decade, Fosun has built a globally integrated innovation system across its core business areas, combining “independent R&D + investment incubation + ecosystem collaboration”, and has consistently made substantial investments in technology innovation. In the first half of this year alone, investment in technology innovation reached RMB4.2 billion, representing a year-on-year increase of 16.7%.In the first half of this year, Fosun saw a series of innovations come to fruition. HANSIZHUANG, independently developed by Henlius, received approval from the National Medical Products Administration (NMPA) for its perioperative indication in gastric cancer, pioneering a postoperative “chemo-sparing” regimen and making it the world’s first and only anti-PD-1 monoclonal antibody approved for this indication. Its core pipeline asset, HLX43, as a potential best-in-class (BIC) broad-spectrum anti-tumor PD-L1 ADC, has demonstrated preliminary clinical efficacy characterized by high efficacy and low toxicity across multiple solid tumors, including non-small cell lung cancer (NSCLC), with over 1,500 patients enrolled globally. To date, Henlius has 10 products approved in over 60 countries and regions, and has benefited over 1.1 million patients.In addition, FUMAINING (luvoxmetinib tablets), independently developed by Fosun Pharma, was approved for the treatment of paediatric and adolescent patients with relapsed or refractory Langerhans cell histiocytosis (LCH), continuing to fill the gap in the treatment of rare diseases. In terms of neurodegenerative diseases, Fosun Pharma expanded its global collaboration with AriBio on AR1001, extending its rights to develop and commercialize the product to key markets including the U.S., Europe and Japan. Meanwhile, post-marketing confirmatory clinical trials for sodium oligomannate capsules have progressed steadily, with more than 1,000 patients enrolled as of 31 July 2026. In addition, HT001, an oral NLRP3 inhibitor for the treatment of Parkinson’s disease in-licensed by Hengtai Bio, an investee and incubated company of Fosun Pharma, commenced its Phase I clinical trial in Australia.Fosun’s innovation achievements demonstrate the forward-looking nature of its innovation strategy and its ability to identify the right opportunities in R&D. As Guo Guangchang remarked at the results presentation, through years of effort, Fosun has built globally integrated innovation capabilities rooted in China. This distinctive strength of Fosun is expected to create greater value for all in the years ahead.“Fosun has never pursued innovation behind closed doors. Instead, we leverage our resource-integration capabilities and a global perspective to drive smart innovation, bringing together the best technologies, teams and supply chains from around the world to solve real problems. This is how we unlock vast market potential,” said Guo Guangchang.Unlocking Value through Global OperationsGlobalization has been another forward-looking strategic move for Fosun. Since its listing in Hong Kong in 2007, when many Chinese companies were still focused primarily on their domestic markets, Fosun had already begun expanding overseas ahead of its peers.Nearly two decades later, as a growing number of Chinese companies embrace the view that they must go global or risk being left behind, and seek to capture overseas markets by taking their products overseas, Fosun has already established a profound business presence in more than 40 countries and regions. With local teams operating overseas, it has successfully operated a number of companies within the Fosun ecosystem. “Global operations” have become a defining feature of Fosun’s globalization strategy and a core engine underpinning the development of its businesses.Guo Guangchang said at the interim results presentation that Fosun continues to strengthen its global operational capabilities. On the one hand, it is helping Chinese products and services enter overseas markets. On the other hand, it is introducing high-quality products and services from around the world into China. Drawing on the global resource-mobilization capabilities it has built over the years, Fosun is able to identify high-quality projects and technologies worldwide and rapidly mobilize the resources needed to advance them.In the first half of 2026, Fosun’s overseas revenue reached RMB49.16 billion, accounting for 56.5% of total revenue, up 3 percentage points as compared to the same period of 2025 and marking a record high in the proportion of overseas revenue.In the field of pharmaceuticals and healthcare, Fosun made substantial progress in the global expansion of innovative drugs and commercial business development. Henlius’ HANSIZHUANG was approved for three new indications in the European Union (EU), while HLX11 (pertuzumab injection) was approved in the EU and HLX14 (denosumab injection) was approved in Canada. At the beginning of 2026, Fosun Pharma entered into a strategic partnership with Eisai for HANSIZHUANG, with an aggregate potential consideration exceeding USD300 million, underscoring how the global value of Chinese innovative drugs is being repriced by international markets.In the first half of the year, Yuyuan generated revenue of RMB532 million in Hong Kong SAR and Macau SAR in the first half of 2026, representing a year-on-year increase of 285.83%, while revenue from the Japanese market reached RMB306 million, representing a year-on-year increase of 6.09%. Laomiao has 15 stores in Hong Kong SAR, Macau SAR, overseas markets and duty-free channels. Club Med has also continued to expand its global footprint, with Club Med Urban Oasis Hangzhou Longwu already open and Club Med South Africa Beach & Safari now in soft opening.Leveraging Fosun’s global ecosystem, Fidelidade in the insurance segment has expanded its business from Portugal to Portuguese-speaking countries and markets across Europe, Latin America, and Africa. Its international business now accounts for 26.7% of its consolidated total business, with continued growth in Portuguese-speaking countries. Meanwhile, Peak Reinsurance has maintained steady growth thanks to its global business footprint.The guiding principle behind Fosun’s globalization strategy is “Combining Global Resources with China’s Capabilities”, deeply integrating China’s manufacturing capabilities, service capabilities, and innovation dividends, with global markets. Starting with leveraging China’s growth momentum to establish its business presence, and progressing to a two-way engagement of “mutual empowerment between China and the world”, Fosun has now entered the 3.0 phase of “global organization + local operations”. In this phase, Fosun “truly operates with a global perspective”, having developed the ability to foster cross-regional, cross-cultural, and cross-organizational synergies within its business ecosystem and support the continued growth of its overseas revenue.At the interim results presentation held on 28 August, Guo Guangchang said: “Fosun’s future development goal is to ‘spur the horse to full speed’. We have already positioned ourselves on a trajectory of steady growth. Going forward, we will continue to advance innovation-driven and global development in industries where we have established competitive advantages, building on our momentum and accelerating further.” Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Redion Holiday Barometer 2026: Singapore Sets a Global Benchmark for the Most Insured Travelers as Expectations for Travel Support Rise ACN Newswire

Redion Holiday Barometer 2026: Singapore Sets a Global Benchmark for the Most Insured Travelers as Expectations for Travel Support Rise

SINGAPORE, August 28, 2026 - (ACN Newswire via SeaPRwire.com) - Singapore has emerged as the world’s most mature travel protection market, with 86% of travelers covered by travel insurance when they travel, the highest rate recorded globally according to the latest Holiday Barometer 2026 report by Redion (formerly Europ Assistance) and Ipsos. Alongside strong risk awareness among Singaporeans, the findings highlight growing expectations for comprehensive protection for a broader scope of travel risks, with real-time assistance and seamless digital support increasingly viewed as essential elements of the travel journey.As one of the region's most active outbound travel markets with frequent, high-spending travelers and digitally engaged consumers, Singapore offers a glimpse into how traveler expectations are evolving amid growing awareness of global risks. The increasing demand for reassurance through travel protection and assistance is posing a challenge for insurers and travel providers beyond driving insurance penetration towards delivering broader protection, stronger assistance capabilities and more integrated travel solutions that support travelers throughout their journeys.Travel protection has become a standard expectationSingapore ranks highest globally for travel insurance and protection coverage, with 86% of travelers covered when traveling and more than half (51%) intending to continue subscribing to travel insurance in the future. This market maturity is reflected in the types of risks Singaporeans choose to protect against, including loss of personal belongings, transportation accidents and health-related incidents, suggesting that travelers increasingly value comprehensive protection that extends beyond basic policy coverage.Singaporeans also remain among the world’s highest-spending travelers, with an average leisure holiday budget of USD 2,818. Yet affordability and company reputation remain important purchasing considerations when selecting travel protection, indicating that consumers are willing to invest in coverage when it offers clear value, trusted service and meaningful benefits.Virginie Babinet, CEO Travel Insurance & Assistance – Redion Group, said, "Building on the record levels seen last year, the desire to travel remains strong and undiminished, despite tougher trade-offs and the cost of living remaining a top global concern. What is changing, however, is the travel landscape itself. Security considerations are weighing more heavily on destination choices, with decisions increasingly shaped by risk considerations. At the same time, artificial intelligence is now a genuine planning tool for a growing number of travelers worldwide, as demonstrated by the distinct jump in numbers, particularly in emerging and high growth markets."Hassen Bennour, CEO of Redion Asia Pacific, said, “Singapore continues to set the pace for travel protection in the region, with 86% of travelers already covered, among the highest levels in the world. What is changing, however, is what travelers now expect this protection to deliver. Beyond coverage, Singaporeans want broader multi-risk protection, embedded assistance and reassurance that travels with them across every trip. At the same time, artificial intelligence is helping travelers plan faster, but confidence in the final decision still rests with human expertise. For insurers and industry partners, this is where the next opportunity lies: pairing digital speed with trusted human guidance to meet the standards of one of the most demanding travel markets globally."AI and digital tools help Singaporeans travel smarter, but human control still leadsSingapore's strong digital adoption is also reshaping how travellers research, plan and manage their journeys. Nearly half (45%) of Singaporeans have used AI in holiday planning or booking, primarily to research destinations, compare travel options and build itineraries. A similar proportion (48%) would consider allowing AI to make bookings on their behalf, provided they retain the ability to review and approve decisions before purchase.The same trend is emerging in travel insurance. While the use of AI to compare travel insurance products remains relatively limited today, many travelers (47%) expect to rely on it more in the future because of the convenience and speed it offers. Interest is also growing in digital services that complement insurance policies, including emergency assistance, 24/7 customer support, real-time alerts, mobile access and digital claims services.The implication is evident that AI is preferred as a tool in the planning process, but decision-making and the trust that comes with it still needs a human checkpoint built into the journey. Rather than replacing human involvement, the findings suggest that travelers want digital convenience supported by visible human oversight, combining the speed of technology with the confidence of expert guidance.Frequent outbound and experience-driven travelers expect reassurance throughout the journeySingaporeans remain among the region’s most active travelers. More than 9 in 10 take at least one leisure trip annually, while the majority (84%) intend to travel internationally, despite persisting geopolitical uncertainty. Travel is increasingly experience-driven, with nearly 7 in 10 preferring city destinations, citing relaxation, exploration and local food and cultural discovery among their key motivations. Combined with high travel spending, these behaviors reflect a market that increasingly prioritizes quality experiences alongside value.As travellers invest more in their trips, expectations around protection and support naturally rise. The research found that concerns around natural disasters, epidemic outbreaks, terrorism and travel disruptions continue to influence travel decisions. Rather than discouraging travel, these concerns are driving demand for greater reassurance, flexibility and support before, during and after each journey. This creates opportunities for insurers and travel providers to embed safety, assistance and peace of mind into the overall customer journey as enablers of worry-free travel experiences.With most travelers taking their longest trips during the year-end period, particularly in November and December, the final quarter remains a critical window for travel providers to engage consumers through premium offerings, bundled experiences and integrated protection solutions. As expectations around travel continue to evolve, Singapore's world-leading level of protection coverage underscores a broader shift in how travellers view insurance and assistance. Increasingly, travellers are seeking protection that delivers peace of mind throughout the entire journey, supported by digital convenience, responsive assistance and trusted expertise whenever they need it.About Redion (formerly Europ Assistance)Redion is a world leader in assistance, travel insurance and employee benefits. The name, revealed in 2026, reflects the full maturity of the global Care platform that has been operating under Generali Care, bringing together Europ Assistance and Generali Employee Benefits (GEB). Operating in more than 190 countries, with over 12,000 employees and €5.8 billion in annual business volume, Redion delivers services spanning travel insurance, emergency and medical assistance, employee protection (life, disability, accident, medical), health and mobility solutions, as well as global B2B2C and embedded insurance programmes. Within its employee benefits offering, Redion builds on a global network of 224 active partners to provide multinational clients with protection, health, pension and wellbeing solutions across markets, combining global scale, local expertise and deep technical capabilities.For media enquiries, please contact:Benedict Gerald Rozario, Marketing & Communication, Redion East AsiaM: +60-12 979 7238E: benedict.rozario@eastasia.redion.comNadzwan Tahir, Senior ExecutiveNarro CommunicationsM: +60-18 399 1646E: nadzwan@narrocomms.com Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Modern Dental Group Announces 2026 Interim Results ACN Newswire

Modern Dental Group Announces 2026 Interim Results

RESULTS HIGHLIGHTS:- The Revenue for the six months ended 30 June 2026 was approximately HK$2,032.5 million, representing an increase of approximately 10.8% as compared to the same period in 2025. The growth in revenue was primarily attributable to the continued organic growth of the Group—driven by the accelerating adoption of digitalization across the global dental industry, particularly in Europe and Australia—alongside the stabilization and operational turnaround of the Mainland China market. This expansion was partially offset by a revenue decline in North America, which was impacted by a softer macroeconomic environment affecting high-value discretionary procedures, as well as management’s strategic decision to rationalize loss-making Dental Service Organization (DSO) accounts to optimize customer mix and protect margins.- The Gross Profit Margin for the six months ended 30 June 2026 was approximately 58.1%; the gross profit was approximately HK$1,180.9 million, reflecting an increase of approximately 17.4% as compared to the same period in 2025.- The Group’s EBITDA for the six months ended 30 June 2026 was approximately HK$ 560.7 million, representing an increase of approximately 22.8% as compared to the same period in 2025.- The Group’s Net Profit for the six months ended 30 June 2026 was approximately HK$ 377.6 million, representing an increase of 30.8% as compared to the same period in 2025.- Basic earnings per share for the six months ended 30 June 2026 amounted to HK40.07 cents, representing an increase of approximately 31.9% as compared to the same period in 2025.- The Board declared an interim dividend of HK14.0 cents per ordinary share for the six months ended 30 June 2026.ADDITIONAL HIGHLIGHTS:- For the six months ended 30 June 2026, the Group’s digital solution cases that are produced from its Mainland China, Thailand and Vietnam production facilities increased to approximately 627,773 cases, reflecting an increase of 29.2% as compared with the same period in 2025 as a result of our clients’ continued adoption of intra-oral scanners.HONG KONG, August 28, 2026 - (ACN Newswire via SeaPRwire.com) - 27 August 2026, Modern Dental Group Limited (“Modern Dental” or “the Group”, stock code: 03600.HK), a leading global dental prosthetic device provider, is pleased to announce the unaudited interim results for the six months ended 30 June, 2026 (“the Period”).In the first half of 2026, the global macroeconomic environment remains uncertain, with geopolitical tensions and potential tariff changes continuing to create headwinds. However, the Group’s geographically diversified production footprint and global distribution network position us strongly to navigate these challenges. Unlike many competitors reliant on single-country manufacturing, our operations across China, Vietnam and Thailand (including the newly acquired Hexa Ceram) provide superior resilience and flexibility. This strategy, combined with our ability to adapt quickly to local market conditions, enables the Group to mitigate risks and capitalise on opportunities across regions.The dental industry has continued to demonstrate remarkable resilience, underpinned by irreversible demographic trends, including aging populations and increasing awareness of oral health, which drive consistent long-term demand. Building on our well performance, the Group is well placed to sustain momentum and further strengthen its market leadership.Digitalisation remains an irreversible industry trend that is accelerating consolidation of the dental prosthetics industry. We are at the forefront of this transformation, with digital solution cases now representing approximately 35–43% of total volume. Our centralized digital workflows, intra-oral scanner partnerships, proprietary solutions and global education centers have enhanced operational efficiency, reduced turnaround times and delivers superior customer experiences. These initiatives create high entry barriers and will continue to drive margin expansion and market share gains in the coming years.European BusinessesDuring the period under review, the European market recorded a revenue of approximately HK$1,093.3 million, representing an increase of approximately HK$173.0 million as compared with the six months ended 30 June 2025. This geographic market accounted for approximately 53.8% of the Group’s total revenue. The increase of revenue from the European market was attributable to the increase in sales order volume driven by the launch of new products, such as digital dentures, and our state-of-the-art digital workflows.North American BusinessesDuring the period under review, the North American market recorded a revenue of approximately HK$331.3 million, representing a decrease of approximately HK$34.4 million as compared with the six months ended 30 June 2025. This geographic market accounted for approximately 16.3% of the Group’s total revenue.The top-line contraction in North America was primarily driven by a softer macroeconomic environment, which temporarily weighed on consumer sentiment and demand for high-value discretionary cosmetic procedures. In response, management proactively initiated a strategic rationalization of loss-making Dental Service Organization (DSO) accounts aimed at optimizing the customer mix, protecting gross margins, and focusing resources on higher-margin accounts.Concurrently, the Group’s diversified production footprint across the US, China, Vietnam, and Thailand continues to afford significant supply chain agility to navigate trade and tariff complexities—a key differentiator in the market. Demonstrating the resilience of this strategy, our US import business unit delivered a 1.4% period-on-period sales growth in the first half of 2026. This performance underscores how the accelerating trend toward clinical digitalization and the cost-competitiveness of our imported product lines have effectively mitigated and offset the impact of US tariffs.Greater China BusinessesDuring the period under review, the Greater China market recorded a revenue of approximately HK$300.0 million, representing an increase of approximately HK$6.8 million as compared with six months ended 30 June 2025. This geographic market accounted for approximately 14.8% of the Group’s total revenue.Regional performance reflected diverging market dynamics across territories. In local currency terms, sales in Mainland China increased by approximately 0.9% year-on-year, signalling that the market has largely bottomed out from the initial impact of Volume-Based Procurement (VBP) policies and prolonged price competition. To protect sustainable profitability, the Group deliberately pivoted away from low-margin segments to focus on serving mid- to high-value customers. Conversely, sales in the Hong Kong market decreased by approximately 8.5% in local currency year-on-year. This contraction was primarily driven by a temporary reduction in local patient visits, as cross-border dental consumption increased due to aggressive promotions for dental treatments offered by Mainland China clinics targeting Hong Kong residents.Despite these near-term shifts, the Group remains optimistic about the mid- to long-term outlook for the Greater China region. Government procurement measures in Mainland China are expected to standardize prosthetic pricing and enhance market transparency, creating a more level playing field where the Group’s leading brand reputation, production scale, and operational efficiency serve as distinct competitive advantages. To capture evolving market demand, the Group is actively expanding its product portfolio, particularly in mid-end offerings and products.Australian BusinessesDuring the period under review, the Australian market recorded a revenue of approximately HK$162.8 million, representing an increase of approximately HK$24.9 million as compared with the six months ended 30 June 2025. This geographic market accounted for approximately 8.0% of the Group’s total revenue. The increase in revenue from Australia was primarily driven by strong adoption of digital dental products and anti-snoring devices, and wins in dental service organization (DSO) customers.Other MarketsOther markets primarily include Indian Ocean countries, Malaysia, Taiwan, Singapore and Thailand. For the six months ended 30 June 2026, these markets recorded a revenue of approximately HK$145.2 million, representing an increase of approximately HK$27.4 million as compared with the six months ended 30 June 2025. This geographic market accounted for approximately 7.1% of the Group’s total revenue. The increase in revenue from Other markets was primarily driven by the strong revenue contributions from Thailand, Singapore and Malaysia. The scaled manufacturing hubs in Thailand and Vietnam have enhanced regional supply efficiency, broadened product availability, and strengthened the Group’s competitive footprint in the region.Future Prospects and StrategiesLooking ahead, the Group remains committed to reinforcing its worldwide leading position through a multi-dimensional approach. We will continue to pursue selective acquisitions, joint ventures and partnerships to expand and complement our product offerings, particularly in our high-growth clear aligner, Trioclear, while strengthening our distribution and sales networks. Ongoing investments in mass-scale production facilities, AI, automation, research and development, and digital innovation will drive efficiency gains and secure our position at the forefront of the industry.With the Board’s extensive experience and prudent governance, the Group is well positioned to seize new business opportunities while remaining strict financial discipline to safeguard Shareholders’ interests. The Board expresses its sincere gratitude to our dedicated employees, loyal customers, suppliers, and business partners for their unwavering commitment. Their collective efforts have been instrumental in delivering another year of record results and will continue to support the Group’s long-term success.About Modern Dental GroupModern Dental Group Limited (Stock code: 03600.HK) is a leading global dental prosthetics provider, distributor and consultant with a focus on providing custom-made prostheses to customers in the growing prosthetics industry. Our product portfolio is broadly categorized into three product lines: fixed prosthetic devices, such as crowns and bridges; removable prosthetic devices, such as removable dentures; and other devices, such as orthodontic devices, sports guards, clear aligners, and anti-snoring devices.Modern Dental Group has a global portfolio of respected brands, including Labocast, Permadental and Elysee Dental in Western Europe, YZJ Dental in China, Modern Dental Lab in Hong Kong, Modern Dental USA and MicroDental in the United States, Modern Dental Pacific in Australia and New Zealand, Modern Dental SG in Singapore, Modern Dental TW in Taiwan, Apex Digital Dental in Malaysia and Hexa Ceram in Thailand. We have grown these brands by providing premium and consistent quality products and superior customer service. We have more than 80 service centers in over 30 countries and serve over 35,000 customers. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Merdeka Gold Delivers Strong Q2 Production Ramp-Up as Pani Gold Mine Advances Toward Full-year Growth ACN Newswire

Merdeka Gold Delivers Strong Q2 Production Ramp-Up as Pani Gold Mine Advances Toward Full-year Growth

HONG KONG, August 28, 2026 - (ACN Newswire via SeaPRwire.com) - 27 August 2026, PT Merdeka Gold Resources Tbk (“Merdeka Gold” or the “Company”; IDX: EMAS; HKEX: 6228), the owner and operator of the Pani Gold Mine, reported a sharp improvement in its first-half financial performance, as the ramp-up of the Pani Gold Mine began to translate into stronger revenue and positive EBITDA.Revenue increased to US$28.2 million in 2Q26 from US$2.6 million in 1Q26, reflecting higher gold sales volume as mining, processing and sales activities at Pani Gold Mine continued to increase.For the first half of 2026, Merdeka Gold booked revenue of US$30.9 million, compared with US$83,786 in the same period last year, as the Pani Gold Mine began generating meaningful gold sales.Gold production increased more than eightfold quarter-on-quarter to 15,594 ounces in 2Q26, bringing first-half production to 17,412 ounces. Gold sales also increased sharply to 6,439 ounces in 2Q26, compared with 516 ounces in 1Q26.The stronger sales contribution lifted Merdeka Gold’s operating performance, with gross margin reaching 44% and EBITDA reaching US$17.0 million in the first half of 2026.Mr. Boyke P. Abidin, President Director of PT Merdeka Gold Resources Tbk, said, “Merdeka Gold’s first-half performance shows that Pani is beginning to contribute meaningfully to the Company’s financial results. Following the strong ramp-up of the heap leach operation during the second quarter, production is expected to be significantly weighted toward the second half of 2026 as mining rates, stacking volumes and gold recoveries continue to improve. Our focus remains on accelerating production, improving operating performance and executing the next phase of growth with discipline.”Beyond the near-term production ramp-up, Merdeka Gold is progressing the next phase of growth at the Pani Gold Mine through the development of its Carbon-in-Leach (“CIL”) project. The CIL pad for the CIL tanks and pre-leach thickener was completed by the end of June, with the overall CIL pad scheduled for completion by the end of December 2026. The CIL facility is expected to come on stream in 2028, strengthening Pani’s long-term production growth profile.With the Pani Gold Mine now generating meaningful revenue and positive EBITDA, Merdeka Gold enters the second half of 2026 with stronger operating momentum. Production is expected to increase significantly as mining rates, stacking volumes and gold recoveries continue to improve, supporting higher sales volumes and stronger operating performance. At the same time, continued progress on the CIL project will lay the foundation for the next phase of Pani’s growth.About PT Merdeka Gold Resources TbkPT Merdeka Gold Resources Tbk (“Merdeka Gold”; IDX: EMAS; HKEX: 6228) is an Indonesian gold mining company majority-owned by PT Merdeka Copper Gold Tbk (IDX: MDKA). The Company was listed on the Indonesia Stock Exchange in September 2025 as part of the Group’s strategy to strengthen its capital structure and enhance transparency.Merdeka Gold’s primary asset is the Pani Gold Mine in Gorontalo, Indonesia, one of the largest primary gold development projects in the country, with mineral resources of 7.0 million ounces of gold and an estimated mine life of approximately 15 years.Production is supported by a Heap Leach facility with an initial capacity of 8 million tonnes per annum. The Pani Gold Mine commenced initial mining activities in October 2025, achieved first gold production in February 2026, and completed its first gold sales in March 2026.The Company also plans to develop a Carbon-in-Leach facility, targeted to commence operations in 2028 and scale up to a capacity of 12 million tonnes per annum by 2029, enabling peak production of approximately 545,000 ounces of gold per year by 2031.DisclaimerThis document: (i) is for information purposes, (ii) may or may not contain certain “forward-looking statements”, (iii) does not constitute or form part of any offer for sale or subscription of or solicitation or invitation of any offer to buy or subscribe for, or sell any securities of PT Merdeka Gold Resources Tbk (“EMAS” or the “Company”) and its subsidiaries (together referred to as “EMAS Group”) or to enter into any transaction under Indonesia Capital Markets Law or any other prevailing laws in any jurisdiction. All statements, other than statements of historical fact, which address activities, events, or developments that EMAS Group believe, expect, or anticipate will or may occur in the future, are forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as “seek”, “anticipate”, “believe”, “plan”, “estimate”, “targeting”, “expect”, “project”, and “intend” and statements that an event or result “may”, “will”, “can”, “should”, “could”, or “might” occur or be achieved and other similar expressions including the negative of those terms or other comparable terminology. These forward-looking statements, including but not limited to those with respect to permitting and development timetables, mineral grades, metallurgical recoveries, and potential production, reflect the current internal projections, expectations, or beliefs of EMAS Group based on information currently available to EMAS Group. Statements in this document that are forward-looking and involve numerous risks and uncertainties that could cause actual results to differ materially from expected results are based on EMAS Group’s current beliefs and assumptions regarding many factors affecting its business (including affect the outcome and financial effects of the plans and events described herein); statements in documents are provided to allow potential investors and/or the reader understand EMAS Group management’s opinions in respect of future. There can be no assurance that (i) EMAS Group have correctly measured or identified all the factors affecting its business or the extent of their likely impact, (ii) the publicly available information with respect to these factors on which EMAS Group’s analysis is complete and/or accurate, and/or correct and/or (iii) EMAS Group’s strategy, which is based in part on this analysis, will be successful. EMAS Group expressly undertakes no obligation to update and/or revise any such forward-looking statements if circumstances or EMAS Group management’s estimates or opinions should change except as required by applicable laws. The reader is cautioned not to place undue reliance on forward-looking statements and extra cautions on capital market trading.No Representation, Warranty or LiabilityWhilst it is provided in good faith, no representation or warranty is made by EMAS and/or any of its affiliates, its advisers, consultants, agents, employees, or any of its authorised representatives as to the accuracy, completeness, currency, or reasonableness of the information in this document and/or provided in connection with it, including the accuracy or attainability of any forward-looking statements set out in this document. EMAS Group does not accept any responsibility to inform you and/or update of any matter arising and/or coming to EMAS Group’s notice after the date of this document which may affect any matter referred to in this document. Any liability of EMAS Group and/or any of its affiliates, consultants, agents, employees, or any of its authorised representatives to you or to any other person or entity arising out of this document pursuant to any applicable law is, to the maximum extent permitted by law, expressly disclaimed and excluded. This document is not guarantee of future performance, and undue reliance should not be placed on them as they involve known and unknown risks and uncertainties, which may cause actual performance and financial results in future periods to differ significantly from any projections of future performance and/or result expressed and/or implied by such forward-looking document. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Nissin Foods Announces 2026 Interim Results ACN Newswire

Nissin Foods Announces 2026 Interim Results

Financial HighlightsFor the six months ended 30 June 2026(HK$ million)20262025ChangeRevenue2,071.02,014.2+2.8%Gross Profit731.0677.0+8.0%Gross Profit margin35.3%33.6%+1.7ppProfit attributable to owners of the Company175.2157.0+11.6%Net profit margin8.5%7.8%+0.7ppAdjusted EBITDA330.8303.2+9.1%Earnings per share (HK cents)16.7915.05+11.6%HONG KONG, August 25, 2026 - (ACN Newswire via SeaPRwire.com) - Nissin Foods Company Limited (“Nissin Foods” or the “Company”, together with its subsidiaries, the “Group”; Stock code: 1475) has announced its interim results for the six months ended 30 June 2026 (“the reporting period”).During the reporting period, the Group delivered solid profit growth, primarily driven by the resilient performance of its instant noodle business. Revenue increased by 2.8% year-on-year from HK$2,014.2 million in 2025 to HK$2,071.0 million in 2026, reflecting continued momentum in its core instant noodle business and broader store coverage in the Chinese Mainland. Gross profit increased by 8.0% year-on-year from HK$677.0 million to HK$731.0 million. Gross profit margin improved by 1.7 percentage points from 33.6% year-on-year to 35.3%, driven primarily by the continued expansion of the higher-margin core instant noodle business, the effective execution of raw material procurement strategies which helped mitigate the impact of raw material price volatility, and improved production efficiency.Profit attributable to owners of the Company increased by 11.6% from HK$157.0 million in 2025 to HK$175.2 million in 2026, representing a net profit margin of 8.5% for the period. The Group’s basic earnings per share increased from 15.05 HK cents to 16.79 HK cents for the period. Adjusted EBITDA increased by 9.1% from HK$303.2 million to HK$330.8 million, representing the Adjusted EBITDA margin of 16.0% for the period, reflecting improved profitability at the operating level.Review and Prospects of Different Business RegionsDuring the reporting period, revenue from the Hong Kong and other regions operations remained stable, increasing by 0.2% to HK$793.5 million (2025: HK$792.3 million), mainly attributable to the continued steady performance of the instant noodle business in the Hong Kong market and increased demand in other regions. Revenue from Chinese Mainland operations increased by 4.5% (in local currency: -0.1%) to HK$1,277.5 million (2025: HK$1,221.9 million), mainly attributable to the increased sales volume of instant noodles and the positive impact of foreign currency translation.In Hong Kong, the instant noodles business delivered steady growth, driven by the resilient performance of flagship brands including Demae Iccho, Hokkaido Iccho, Cup Noodles and Cup Noodles BIG. To further enrich its instant noodle portfolio, the Group introduced a range of new SKUs, such as Nissin Stir Cup Noodles Seafood Flavour Instant Noodle and Nissin Viet Signature Beef Flavour Pho Noodle, and Demae Iccho Scallop and Salt Soup Flavour Instant Noodle. Continuing its IP promotion strategy, the collaboration with Japanese virtual singer “Hatsune Miku” also enhanced brand awareness and strengthened engagement with younger consumers.As for non-noodle business, the Group expanded its premium frozen food portfolio with the launch of the “Doll Dim Sum” series. The Group also introduced a series of limited-edition products to capture seasonal demand and drive sales. Meanwhile, health-focused products, including the Hong Kong-made Nissin Granola and fresh-cut vegetable, continued to gain popularity, reflecting the Company’s commitment to health and wellness. In May 2026, the Group entered into a strategic partnership with Itochu Hong Kong Limited through a joint investment in Nissin Marketing and Sales (H.K.) Limited, which is expected to support the long-term development and competitiveness of the distribution business in Hong Kong and the Chinese Mainland.In other regions, the Company continued to strengthen its presence in Vietnam with a focus on the youth segment to support instant noodles brand growth and market penetration. In Korea, Gaemi Food’s business performance was stable during the period, with the strategic focus on the expansion of its e-commerce business, enhancement of consumer engagement through “KEMY Mall”, and continuous product innovation. Gaemi Food continued to expand its presence in overseas markets including Hong Kong, Vietnam, and Taiwan. In Australia, ABC Pastry recorded stable performance supported by the launch of a range of new premium products. Australia Nissin also maintained solid business momentum during the period, driven by increased sales of instant noodles across nationwide supermarket chains and Asian supermarket channels through ongoing market development efforts and product innovation.In the Chinese Mainland, the Group continued to advance its premiumisation strategy and strengthen its business foundation, while increasing instant noodle sales volume through broader market coverage and more diversified distribution channels. It upgraded select Cup Noodles products by increasing ingredient sizes to deliver an improved tasting experience for consumers. To further enrich its product line-up, the Company also introduced new products such as Nissin U.F.O. Singapore Chilli Crab Flavour, reinforcing its premium and innovative brand positioning. The Company continued its collaboration with the Japanese virtual singer "Hatsune Miku" to raise brand awareness and strengthen connections with consumers. As for the non-noodle business, the Company continued to strengthen its snacks, beverage and frozen food businesses through product innovation to address evolving consumer demand.Mr. Kiyotaka ANDO, Executive Director, Chairman and Chief Executive Officer of Nissin Foods, said, “Despite continuing market volatility and geopolitical uncertainties, the Group delivered solid profit growth in the first half of 2026. This was supported by broader market coverage and the resulting increase in sales volume of our flagship brands. These results reflect the resilience of our business model and the effectiveness of our strategic initiatives. Our premiumisation strategy, diversified product portfolio and disciplined cost management have further strengthened our capability to navigate changing market conditions. As we continue to expand our presence in Hong Kong, the Chinese Mainland and overseas markets, we remain focused on delivering quality products and strengthening our brands. We are committed to achieving sustainable long-term growth and creating value for our shareholders.”About Nissin Foods Company LimitedNissin Foods Company Limited ("Nissin Foods”, together with its subsidiaries, the “Group”; Stock code: 1475) is a renowned food company in Hong Kong and the Chinese Mainland, with a diversified portfolio of well-known and highly popular brands, primarily focusing on the premium instant noodle segment. The Group officially established its presence in Hong Kong in 1984 and is the largest instant noodle company in Hong Kong. The Group primarily manufactures and sells instant noodles, high-quality frozen food products, including frozen dim sum and frozen noodles, and also sells and distributes other food and beverage products, including retort pouches, snacks, mineral water, sauce and vegetable products under its two core corporate brands, namely “NISSIN” and “DOLL” together with a diversified portfolio of iconic household premium brands. The Group’s five flagship product brands, namely “Cup Noodles”, “Demae Iccho”, “Doll Instant Noodle”, “Doll Dim Sum” and “Fuku” are also among the most popular choices in their respective food product categories in Hong Kong. In the Chinese market, the Group has introduced technology innovation through the “ECO Cup” concept and primarily focuses its sales efforts in first- and second-tier cities. In addition, Nissin Foods operates business in other regions including Vietnam, Taiwan, Korea and Australia markets.Nissin Foods is currently a constituent of five Hang Seng Indexes, namely: Hang Seng Composite Index, Hang Seng Composite SmallCap Index, Hang Seng Composite Industry Index - Consumer Staples, Hang Seng SCHK Consumption Index and Hang Seng SCHK Consumer Staples Index. Nissin Foods is eligible for trading under Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect. For more information, please visit www.nissingroup.com.hk. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
The World’s Leading Minds in Biotechnology Will Meet in Riyadh This September ACN Newswire

The World’s Leading Minds in Biotechnology Will Meet in Riyadh This September

RIYADH, KSA, Aug 28, 2026 - (ACN Newswire via SeaPRwire.com) - The Riyadh Global Medical Biotechnology Summit has published the scientific program for its fourth edition, and the names on it belong to the people currently deciding what medicine will be able to do in the next twenty years. Sixty confirmed speakers and moderators from eleven countries are named across three days, from 14 to 16 September 2026, at the Sofitel Riyadh Hotel and Convention Centre.Among them are Prof. Jin-Soo Kim of KAIST, whose work on mitochondrial DNA editing reaches beyond CRISPR; Dr. Matthew H. Porteus of Stanford University, engineering genetic circuits into cell-based medicines; Dr. Alex Shalek of MIT; Prof. Vijay Kuchroo of Harvard Medical School; Prof. Keith T. Flaherty of the Massachusetts General Hospital Cancer Center and President of the American Association for Cancer Research; Prof. George F. Gao of the Chinese Academy of Sciences; President Mitsuo Ochi of Hiroshima University; and Dr. Zdenko Herceg of the International Agency for Research on Cancer.They are joined by the people who move science into the world. Dr. Steve Yang, Co-CEO of WuXi AppTec, and Mr. Alec Reynolds of Flagship Pioneering open the program on global partnership. Mr. Kasim Kutay, Chief Executive Officer of Novo Holdings, speaks on where capital should go next. Dr. Hyun-Young Park, Deputy Minister of the Korea National Institute of Health, delivers the closing keynote. Alongside them stand the Saudi institutions building a biotechnology sector in real time: KAIMRC, Lifera, HUMAIN, SPIMACO, KAUST, the Saudi Food and Drug Authority, and Astronaut Rayyanah Barnawi on what the human immune system does in space.The program runs across six tracks: artificial intelligence in biotechnology, multi-omics, biotech investment, immunology, bioengineering and synthetic biology, and biotech workforce development. Its defining feature is that discovery and delivery share the same stage. Genome editing and population genomics sit beside regulation, domestic manufacturing, and procurement, and in several sessions the scientists and the regulators are on the same panel. That is the premise of the Kingdom's National Biotechnology Strategy, which targets $34.6 billion in non-oil GDP from biotechnology by 2040: a discovery is worth only as much as the system available to carry it to a patient."Biotechnology is where the health of every nation will be decided over the next twenty years. Saudi Arabia has chosen not to watch that happen from a distance. We are building the laboratories, the manufacturing, the regulatory ecosystems, and above all, the bio-workforce talent. And we are building it in partnership with the world, under one roof.That is what this Summit is for. Its themes highlight where medicine and biotechnology converge to shape the future of biosciences.Discoveries and breakthroughs are transforming how we care for patients. The diversity of emerging technologies and therapies is creating significant opportunities to explore, advance, invest, and translate scientific progress into better health outcomes. Please join us in Riyadh this September." H.E. Prof. Bandar bin Abdulmohsen Al-Knawy, Chief Executive Officer of Health Affairs, Ministry of National Guard, and President, King Saud bin Abdulaziz University for Health SciencesThe Summit is organized and supervised by the Ministry of National Guard, represented by its Health Affairs sector, and hosted by King Abdullah International Medical Research Center (KAIMRC) and King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), with the Ministry of Investment and Invest Saudi serving as strategic partners. The fourth edition is expected to welcome more than 15,000 visitors, over 200 biotechnology and healthcare brands, and delegations from more than 70 countries, under the theme Building the Foundations of Biotechnology Excellence.The full scientific program is attached and available at rgmbs.org, where registration is open for delegates, exhibitors, and industry partners. Follow the Summit at #RGMBS2026.For further information regarding summit programing visit: https://rgmbs.org/program#conference-agenda About the Riyadh Global Medical Biotechnology SummitThe Riyadh Global Medical Biotechnology Summit is the Kingdom of Saudi Arabia's flagship platform for medical biotechnology, convening the global scientific, investment, and policy communities in Riyadh. Organized and supervised by the Ministry of National Guard, represented by its Health Affairs sector, and hosted by KAIMRC and KSAU-HS, the Summit advances the goals of the National Biotechnology Strategy and supports the Kingdom's emergence as a global destination for health innovation. The fourth edition takes place from 14 to 16 September 2026 in Riyadh.For Media InquiryEmail: PR@legends.sa Telephone: +966 559 810 777 Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Overseas Growth Gathers Momentum as CanSinoBIO’s Global Strategy Unlocks New Opportunities ACN Newswire

Overseas Growth Gathers Momentum as CanSinoBIO’s Global Strategy Unlocks New Opportunities

HONG KONG, August 27, 2026 - (ACN Newswire via SeaPRwire.com) - CanSino Biologics Inc. (“CanSinoBIO,” 06185.HK/688185.SH) released its financial results for the first half of 2026. The Company reported revenue of approximately RMB 550 million, up 43.8% year on year, while its net loss attributable to shareholders narrowed significantly. Notably, while demand in China’s vaccine market remains challenging, CanSinoBIO’s international business maintained strong growth momentum, generating overseas revenue of RMB 150 million during the reporting period. As established products accelerate their expansion into overseas markets, and collaboration models such as technology partnerships and localized industrialization continue to take shape, CanSinoBIO’s overseas business is evolving from a strategic initiative into an increasingly important contributor to the Company’s performance. This reflects the Company’s forward-looking understanding of global vaccine market trends and evolving demand in international markets.At a time when the vaccine industry is facing changes in demand structure, the combination of domestic innovation capabilities and access to international markets is becoming an increasingly important measure of corporate growth resilience.Overseas Growth AcceleratesIn the first half of 2026, China’s vaccine industry continued to face demand-side pressure. As the target population for infant and young-child vaccination continues to decline, demand pressure on traditional pediatric vaccines has become increasingly visible. “Volume contraction and price decline” has emerged as a widespread challenge across the industry.Based on disclosed financial results across the sector, this pressure appears to be industry-wide. In 2025, Zhifei Biological generated RMB1.187 billion in revenue from self-developed products, up 1.23% year on year. Walvax Biotechnology reported 2025 revenue of RMB2.418 billion, down 14.29% year on year; despite a 53.36% year-on-year increase in batch-release volume for its core 13-valent pneumococcal conjugate vaccine, revenue remained under pressure. Kangtai Biological reported revenue of RMB1.273 billion in the first half of 2026, down 8.55% year on year.Against this industry backdrop, the growth of CanSinoBIO’s international business is particularly noteworthy. The Company reported overseas revenue of RMB 150 million in the first half of 2026. This growth was driven, on the one hand, by the continued expansion of mature products into overseas markets and, on the other, by the further deepening of the Company’s international partnership models. For CanSinoBIO, this also means that its products, manufacturing processes and quality control capabilities, validated in the domestic market, are beginning to unlock value overseas through more diversified approaches.Meanwhile, the Company continues to advance its international market footprint. Registration filings and commercialization efforts remain underway across Southeast Asia, South America and the Middle East. Menhycia(R) has obtained registration approvals in Indonesia and Argentina, and product supply has already commenced in Indonesia. As more products progress through overseas registration and commercialization, CanSinoBIO’s international business is expected to develop more diversified revenue streams and further strengthen its commercial resilience.From this perspective, CanSinoBIO’s globalization strategy is evolving. Overseas markets are no longer merely destinations for mature products, but are increasingly becoming markets in which products, technologies and industrial capabilities can jointly create value. For an innovative vaccine company, this shift from “exporting products” to “exporting capabilities and systems” creates greater room for long-term growth in its overseas business.Portfolio Upgrades Strengthen the Commercial FoundationSustained overseas expansion is underpinned by a stable product portfolio and strong technological capabilities.According to the Company’s interim report, domestic revenue continued to grow despite factors such as changes in value-added tax, reflecting opportunities created by ongoing innovation. Menhycia(R), China’s first quadrivalent meningococcal conjugate vaccine, expanded its indicated population in February to children aged 3 months to 6 years, broadening its addressable population. Meanwhile, iPneucia(R), a 13-valent pneumococcal conjugate vaccine featuring dual-carrier technology (CRM197/TT), offers a differentiated option for pediatric pneumococcal disease prevention in China. Since its launch in September 2025, iPneucia(R) has continued to expand market access and is now available in nearly 30 provincial-level markets across China.From meningococcal disease to pneumococcal disease, CanSinoBIO is using innovative products to address vaccine segments that continue to offer meaningful unmet demand. As traditional vaccine categories face pressure on volumes, structural growth driven by product and technology upgrades is providing important support for the Company’s commercial resilience.More importantly, the product-development and industrialization capabilities established in the domestic market also provide a foundation for overseas expansion. For an innovative vaccine company, successful commercialization in China not only broadens revenue sources, but also validates the manufacturing, quality-control and supply systems required to replicate and extend those capabilities into international markets.Domestic product upgrades and overseas business growth are thereforeclosely connected rather than separate. The former provides the foundation in products and technologies, while the latter expands the geographic boundaries within which those products can realize their value.Multi-Layered Pipeline Takes Shape to Support Future GrowthFor an innovative vaccine company, long-term growth depends not only on the commercial performance of existing products, but also on the ability to maintain a steady flow of new products. By pursuing continued ramp-up of marketed products, advancing products under regulatory review and developing next-generation candidates, CanSinoBIO is building a more sustainable and well-sequenced product pipeline.Tripecia(R) (DT3cP Infant), CanSinoBIO’s three-component acellular diphtheria, tetanus and pertussis combined vaccine for infants, received NDA approval in April 2026, becoming the first approved three-component DTP vaccine in China. In August 2026, the first commercial batches received the Certificate for Batch Release of Biological Products. Provincial tendering and market-access processes are progressing in an orderly manner, and the product has begun entering the market supply stage.While Tripecia(R) represents an upgrade in pertussis vaccination for infants, the Td5cp vaccine for adolescents and adults — which has also been granted Priority Review status — is expected to extend CanSinoBIO’s pertussis vaccine portfolio to a broader population. The New Drug Application for Td5cp has been accepted by China’s National Medical Products Administration (NMPA).In addition, CanSinoBIO’s independently developed Adsorbed Tetanus Vaccine, Tetcia(R), has been formally approved, further strengthening the Company’s adult vaccine portfolio. From infants to adolescents and adults, and from individual products to a multi-product portfolio, this strategy is broadening the foundation for future commercial growth.In pneumococcal vaccines, CanSinoBIO’s 24-valent Pneumococcal Polysaccharide Conjugate Vaccine (CRM197/Tetanus Toxoid) (PCV24) formally initiated Phase I/II clinical trials in May 2026, and participant enrollment across different cohorts is progressing as planned. At the same time, the Company continues to advance development of its DT3cP-Hib-MCV4 combination vaccine, extending its portfolio toward increasingly multivalent and combination vaccine formats.Over the longer term, CanSinoBIO is continuing to build its mRNA platform and explore applications in preventive vaccines and therapeutic biologics. The Company is conducting early-stage research into mRNA applications for glioblastoma, rhabdomyosarcoma and cervical cancer, while also exploring in vivo CAR therapies. These programs remain at an early stage, with the Company continuing to assess the potential of mRNA and related technologies in disease treatment. Additionally, on August 25, CanSinoBIO announced that its subsidiary, CanSino Shanghai, had entered a strategic collaboration with deepGeneAI on mRNA therapeutic cancer vaccines. The two parties will leverage their respective strengths in mRNA vaccine technology and tumor neoantigen discovery and design to jointly advance the development and commercialization of personalized mRNA therapeutic cancer vaccines.These pipeline programs represent extensions of CanSinoBIO’s existing technology platforms and product-development experience. The Company’s core platforms — including viral vector vaccines, synthetic vaccines, protein structure design and VLP assembly, mRNA vaccines, as well as formulation and delivery technologies — provide a foundation for continued product iteration and technology translation.Innovation Supports Long-Term DevelopmentViewed in the context of its 2026 interim results, CanSinoBIO’s story is not simply one of revenue growth.Against a changing domestic vaccine demand structure, innovative products have continued to deliver solid commercial performance, demonstrating the resilience created by product upgrades. Overseas business model expanded beyond finished-product exports to include technology collaboration and local manufacturing capabilities, indicating that international markets are becoming a new source of growth. At the same time, Tripecia(R) has entered the market supply stage, the Td5cp vaccine for adolescents and adults is progressing through regulatory review, and pipeline programs including PCV24, multivalent and combination vaccines, and mRNA technologies continue to advance, providing both product succession and technology reserves for the future.These three pathways ultimately point to the same growth logic: domestic innovation capabilities form the product foundation, overseas expansion broadens the commercial opportunity, and sustained R&D determines whether growth can continue over the long term.In an environment where demand for traditional vaccines is under pressure and industry competition is intensifying, growth is increasingly shifting away from reliance on product-volume expansion alone and toward a model jointly driven by product upgrades, technological innovation and global markets. For CanSinoBIO, continued growth in the overseas business is providing increasingly visible financial evidence of this transition.As more innovative products enter the market, more mature products expand overseas and the Company’s technical capabilities extend further into international value chains, CanSinoBIO’s growth runway is expanding from a single domestic market to the global market. For the Company, internationalization is not only about broadening geographic reach; it is also an important pathway for innovative products and technologies to realize greater commercial value while contributing to global public health. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
VVater Expands Global Presence Through New Partnership in Asia-Pacific and the Middle East ACN Newswire

VVater Expands Global Presence Through New Partnership in Asia-Pacific and the Middle East

AUSTIN, TX, Aug 27, 2026 - (ACN Newswire via SeaPRwire.com) - VVater, America's Next Water Company and the world's premier innovator in advanced water treatment solutions, today announced an expanded international presence across Asia-Pacific Middle East (APME) as the company continues to scale its innovative water treatment technology globally and support new sectors.Via a new partnership agreement, VVater APME will be established. This newly formed venture will bring VVater's technology to a wide range of markets and strategic customers around the world as water scarcity, water quality, regulatory expectations and long-term water stewardship become increasingly important drivers of operational resilience and economic performance.VVater APME is a partnership formed between VVater and Ecosafe International, a regionally recognised water risk management and water stewardship consultancy, which supports organisations to navigate their water journey through governance, assurance, risk reduction and practical innovation. With an extensive track record supporting organisations including BHP, Rio Tinto, Chevron, Shell, JLL and NEOM, Ecosafe advises governments, mining operators, healthcare and industrial organisations on achieving safer, more sustainable and more resilient water outcomes across APME. VVater APME will operate with dedicated sector exclusivity in Australia, New Zealand, Saudi Arabia, Qatar and the UAE."What drew us to this partnership is how much overlap there already was," said Kevin Gast, CEO and Chairman of VVater. "Ecosafe has spent years building trust with operators in some of the toughest water environments in the world. Pairing that with our technology means we can move faster into markets that badly need it.""For years we've watched clients wrestle with sourcing credible, provable water treatment technology once a risk assessment tells them what they're up against," said Ryan Milne, Founder of Ecosafe International. "This partnership closes a critical gap for us. We've always helped clients understand and govern water risk. Now we can combine that trusted advisory capability with proven technology solutions that accelerate the transition from water risk to water certainty."VVater APME is designed with a defined path to expand into installation, operations, and eventually in-territory manufacturing, creating long-term capability and supporting regional water security outcomes as the partnership matures.The agreement gives VVater APME access to VVater's full suite of proprietary technology, led by the Farady Reactor, a breakthrough in water treatment. Wherever it's deployed, from remote, self-managed water systems and mine sites to municipal water systems and industrial plants, the Farady Reactor transforms wastewater, sewage and drinking water alike, offering a glimpse of what next-generation water infrastructure can look like.VVater APME is the latest step in the company's international growth, following recognition from TIME, CES and Fast Company, and deployments with partners including Nestle and the City of Bastrop, Texas. The agreement reflects VVater's continued push to bring advanced treatment and reuse technology into markets facing mounting water stress.About VVaterVVater is America's Next Water Company, delivering the future of purification through its award-winning Farady Reactor (Time Best Invention Award 2025, CES Best of Innovation 2025, World Future Award 2025. The first company in history to win all 3 in 1 year achieving a Triple Crown), proprietary ALTEP (Advanced Low Tension Electroporation Process), Advanced Dissolved Air Flotation, and Micro & Nano Bubble technologies. Unlike outdated chemical, filtration, and membrane systems, VVater's electric-field breakthroughs eliminate microplastics, microorganisms, and other contaminants with record retention times, without producing toxic byproducts or requiring costly consumables. With over 4.3B gallons treated and validation from global leaders, VVater is scaling into municipal drinking water and wastewater, DPR/IPR, onsite reuse for data centers, commercial buildings, and resorts, residential purification, and consumer health water, delivering a 60% smaller footprint, 40% CapEx savings, 80% OpEx savings, and 40% less energy use. For more information, please visit www.vvater.com.Contact InformationVVATER Media OfficeGlobal Media Roommedia@vvater.comNicholas Koulermosvvater@5wpr.comSOURCE: VVater LLC Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Iggy Azalea Invests in Shift – The AI Company Behind the Fastest-Growing Platform in the $1.3 Trillion Creator Economy, Fanvue ACN Newswire

Iggy Azalea Invests in Shift – The AI Company Behind the Fastest-Growing Platform in the $1.3 Trillion Creator Economy, Fanvue

LONDON, Aug 27, 2026 - (ACN Newswire via SeaPRwire.com) - Iggy Azalea, the four-time Grammy-nominated artist, entrepreneur, and active investor, has personally invested a substantial sum in Fanvue's parent company SHIFT - the AI infrastructure the platform runs on. As part of the investment deal, Azalea will also become the founding member of SHIFT's Creator Advisory Board.The move comes at a time when the world's biggest creators, athletes and music artists are increasingly looking to multi-million-dollar equity opportunities in the creator economy - recent examples include MrBeast and the Paul brothers, Jake and Logan.AI is transforming how people make money online. For two decades, the creator economy has run on a simple trade: creators build the audience, and advertisers rent it. That era is ending. Advertising isn't going away, but something else is the future: fans paying creators directly, for subscriptions, communities, experiences and digital products. Direct monetisation is the fastest-growing force in a creator economy projected to reach $1.3 trillion by 2033 (Grand View Research), and it hands creators what advertising never did: ownership of their income."I've spent my career watching the value creators generate flow everywhere except to the actual creators themselves," said Azalea. "Every now and then a Stripe or a Shopify comes along and changes who holds the leverage. I'm backing SHIFT to be that company for the creator economy. And I'm not just the face, I'm an owner."SHIFT's flagship platform, Fanvue, surpassed a $200 million annualised run rate in July - five months earlier the business hit $100m, making it the fastest-growing platform in the creator economy. The platform is home to Cardi B, footballer Alisha Lehmann, WNBA star Kysre Gondrezick and football journalist Fabrizio Romano. The business closed a $22 million Series A in January led by Inner Circle, the investment club whose portfolio includes Revolut, Anthropic and xAI.Fanvue was launched in 2020 by Joel Morris, Will Monange and Harry Fitzgerald. Morris, a teenage YouTube star with more than 2.5 million subscribers, saw the model from the inside: the audience was his, but the earnings ran through advertisers, not fans. Fanvue was built to flip that - and as it has scaled, the vision outgrew the platform alone and became SHIFT.SHIFT was built to transform how the creator economy earns. At its centre is Fanvue, the AI-first platform where creators run their businesses; around it, SHIFT is building a growing ecosystem of apps that expands what creators can sell, payment rails built for a new era of AI-driven & agentic commerce, and financial services designed to scale creator earnings. Creators using SHIFT's AI tools earn between three and six times more than those who don't."AI is fundamentally changing how people make money online, and global talent like Iggy investing in SHIFT underlines the belief in our vision" said Joel Morris, Co-Founder and Co-CEO."For twenty years creators could only really sell one thing, their audience's attention, and advertisers were the only buyer. AI removes that ceiling," said Will Monange, Co-Founder and Co-CEO."Iggy shares the same vision as the SHIFT team - build the AI infrastructure that the whole creator economy will run on." said Harry Fitzgerald, Co-Founder & COO.About SHIFT: SHIFT is the AI infrastructure company for the creator economy, spanning the Fanvue platform, its AI engine, the first app store on any creator platform, and payment and financial rails. Founded in 2020 and headquartered in London.About Fanvue: Fanvue is the fastest-growing platform in the creator economy, with 17+ million monthly active users and over 325,000+ creatorsAbout Iggy Azalea: Four-time Grammy nominee, multi-platinum recording artist, and active entrepreneur and investor.Contact informationRyan Michael Gilksryan@ideafarmer.co.uk07568490267SOURCE: Shift Holdings Ltd Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Reconova Technologies Interim Results ACN Newswire

Reconova Technologies Interim Results

XIAMEN, August 27, 2026 - (ACN Newswire via SeaPRwire.com) - August 26, 2026, Reconova Technologies Co., Ltd. ("Reconova" or the "Company", Stock code: 7656.HK) today released its first interim results since its listing. During the reporting period, the Company achieved revenue of approximately RMB102 million, representing a year-on-year increase of 58.7%. The revenue growth was primarily driven by the synergistic momentum across its three business segments, underpinned by a solid core business foundation. R&D expenses accounted for approximately 48.8% of revenue, as strategic investments continued to build robust technological moats for the Company.Operating Performance Steadily Improves, Operational Efficiency Continuously OptimisedFrom a profitability perspective, the Company recorded a net loss of approximately RMB64 million during the reporting period, narrowing by 6.7% year-on-year. This improvement was achieved despite a continued increase in R&D investment, which rose 51.2% year-on-year. As the Company is in the strategic investment phase for embodied intelligence, R&D expenses account for nearly half of revenue. The net loss was primarily attributable to increased R&D investment in embodied intelligence and one-off listing-related expenses incurred during the period.In terms of operational efficiency, selling and distribution expenses declined by approximately 5.3% year-on-year alongside revenue expansion, reflecting continuous efficiency gains. While the net loss narrowed year-on-year, trade receivables decreased to approximately RMB510 million, down 13.0% from the end of the previous year, indicating a notable improvement in collection efficiency.Looking at forward revenue visibility, contract liabilities stood at approximately RMB12 million as at the end of the reporting period, up 420% from the beginning of the year. Contract liabilities represent advance payments from customers for goods or services not yet delivered; these amounts will be progressively recognised as revenue in subsequent accounting periods, providing greater visibility into future revenue.. For technology companies in a strategic investment phase, trends in contract liabilities often better reflect the true trajectory of the business than current-period net profit.Three Business Segments Achieve Synergistic Growth, Customer Ecosystem Continuously StrengthenedDuring the reporting period, all three business segments achieved year-on-year growth with ongoing structural optimisation, demonstrating the core business's sustainable cash-generating capability.The Intelligent Civil Aviation segment generated revenue of approximately RMB3 million, up 319.1% year-on-year, benefiting from enhanced customer stability. The Company maintained its No. 1 market position in China's enterprise vision intelligence product market for civil aviation, with its products deployed in over 60% of China's airports with annual passenger throughput exceeding 10 million. Benchmark projects continue to be replicated and iterated. It is worth noting that the civil aviation sector exhibits pronounced seasonal characteristics: due to the annual budget execution cycle of airports and project acceptance timelines, revenue recognition for this segment is typically concentrated in the second half of the year, particularly in the fourth quarter.The Smart Commercial segment accelerated the acquisition and servicing of high-value customers, driving growth in average customer value and transaction volume. Revenue reached approximately RMB34 million, up 95.5% year-on-year. The SINHON Business System for commercial spaces is being deployed at an accelerating pace, achieving rapid growth and a more diversified revenue base.The Smart Driving Safety segment generated revenue of approximately RMB66 million, up 41.2% year-on-year. A significant increase in new customer order volumes drove sales expansion.Full-Stack Technology System Evolves, Embodied Intelligence Achieves Multiple Commercialisation MilestonesWith 14 years of expertise in vision intelligence, Reconova has built an integrated enterprise-grade embodied intelligence core technology framework spanning "perception–cognition–physical execution," and is steadily advancing the large-scale deployment of commercial robot products for productivity-focused scenarios.In terms of concrete progress, the "AntOne" airport baggage handling robot, launched in September 2025, has completed pilot deployment at a major Chinese airport with more than 10 million annual passengers, supporting 24/7 uninterrupted operation. In April 2026, the Company iteratively launched its new VTFLA embodied intelligence technology architecture. Building on the conventional VLA (Vision-Language-Action) framework, VTFLA integrates multi-modal input perception including vision, tactile and force feedback. Its core design philosophy is to process over 80% of intelligence at the edge, employing a dual-system fast-slow coordination architecture that decouples and coordinates task planning with real-time control. The Company plans to further advance R&D in edge-side lightweight embodied intelligence technology, continuously enhancing multi-modal perception and execution capabilities.At the recently concluded 2026 World Robot Conference (WRC), the Company comprehensively presented an embodied intelligence solution for airport productivity scenarios. Through human-machine systems and multi-robot collaborative operations, the solution reshapes traditional manual baggage handling operations, creating a safe, reliable, and flexibly adaptable full-chain intelligent baggage handling system. In addition, the Company has initiated R&D on a wheeled dual-arm robot, expected to be launched in 2027 and commercialised in 2028. Its application scenarios will expand from fixed-position baggage handling to mobile loading and unloading operations under aircraft, and gradually extend to warehousing, industrial automation, and other scenarios. During the conference, the Company also signed a strategic cooperation agreement with SIIC Tech Capital to jointly build the Hong Kong Embodied Intelligence Super Accelerator, advancing industrial commercialisation and international expansion.Globalisation Strategy Fully Launched, Overseas Markets Achieve Multi-Point BreakthroughsFor international expansion, the Company adopts a strategy of "expanding from nearby markets to more distant regions," with an initial focus on Southeast Asia and the Middle East. Currently, the Company has launched Proof of Concept (PoC) pilot projects at Hamad International Airport in Doha, Qatar, and Tashkent International Airport in Uzbekistan. The rollout follows the principle of "prioritising flagship airports first, then radiating to long-tail customers": the first phase focuses on hub airports in the Middle East and Southeast Asia to establish benchmark cases, before progressively expanding to long-tail customers and subsequently entering European and American markets. The Company is replicating its vision AI and embodied intelligence experience accumulated at domestic airports to global markets that are undergoing large-scale smart airport construction.In terms of partnership models, the Company emphasises local ecosystem collaboration and the export of technology standards, combined with product localisation, adopting an asset-light, deep-collaboration approach. Approximately 10.4% of the IPO net proceeds have been earmarked for expanding overseas sales channels, providing financial support for the globalisation strategy.Strategy Focused on Productivity Scenarios, Long-Term Market Potential Gradually UnlocksThe Company adheres to a highly focused and disciplined strategic principle, concentrating on "productivity tools" in handling, depalletizing/palletizing, and specialty scenarios, rather than pursuing broad concepts such as consumer-grade robots or general-purpose humanoid robots. In the short term, the three business segments — Intelligent Civil Aviation, Smart Commercial, and Smart Driving Safety — will continue to generate stable cash flow. Over the medium to long term, leveraging a universal vision intelligence foundation reusable across scenarios, the Company will continuously strengthen its full-stack embodied intelligence core technology framework, iterate multiple categories of commercial robots, and complete a strategic upgrade from vision intelligence solutions to an integrated "perception–cognition–physical execution" enterprise-grade embodied intelligence framework.Embodied intelligence has been included as a key future industry to be cultivated under China's 15th Five-Year Plan. According to Frost & Sullivan forecasts, China's enterprise vision intelligence market will exceed RMB162.7 billion by 2030. As B2B customers' demand for cost reduction and efficiency improvement continues to rise and the technology maturity curve crosses its inflection point, commercial robots are expected to enter a period of accelerated demand growth in productivity scenarios such as airport baggage handling, warehousing logistics, and industrial automation over the next three to five years.Leveraging its 14-year vision intelligence foundation and multi-scenario engineering delivery experience, Reconova is accelerating the deployment of embodied intelligence in real industrial scenarios, completing its transition from vision intelligence to enterprise-grade embodied intelligence, with long-term market potential gradually unlocking.About Reconova Technologies Co., Ltd. Reconova Technologies Co., Ltd. (Stock code: 7656.HK) is a leading enterprise vision intelligence company in China, listed on the Main Board of The Stock Exchange of Hong Kong Limited on 8 July 2026. The Company provides a series of visual perception, visual cognition, and visual reasoning intelligence products applied across civil aviation, commercial spaces, and driving safety scenarios. Ranked first in China's enterprise vision intelligence product market for civil aviation by 2025 revenue, Reconova is advancing its strategic evolution from vision intelligence to enterprise-grade embodied intelligence. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Watch & Clock Fair, Salon de TIME return this September ACN Newswire

Watch & Clock Fair, Salon de TIME return this September

HONG KONG, August 27, 2026 - (ACN Newswire via SeaPRwire.com) - The 45th Hong Kong Watch & Clock Fair and the 14th Salon de TIME, jointly organised by the Hong Kong Trade Development Council (HKTDC), Hong Kong Watch Manufacturers Association Limited, and the Federation of Hong Kong Watch Trades & Industries Limited, will be held from 1 to 5 September at the Hong Kong Convention and Exhibition Centre (HKCEC). Salon de TIME will be fully open to the public throughout the event.The 45th HKTDC Hong Kong Watch & Clock Fair and 14th Salon de TIME take place from 1 to 5 September at the Hong Kong Convention and Exhibition Centre. Introducing fair highlights at a press conference are Smilely Lam, HKTDC Associate Executive Director (fifth from the left), SK Chong (fourth from the right) and Frankie Lam (fourth from the left), Co-Chairmen, HKTDC Hong Kong Watch & Clock Fair Organising Committee 2026, and celebrity Joey Thye (fifth from the right).Under the theme “Sparkling Moments Through Time”, the two fairs are expected to attract more than 630 exhibitors from 16 countries and regions, showcasing a wide range of watches, clocks and related products to meet evolving market trends and consumer demand.The Click2Match AI-powered business matching platform has been available since 25 August and will remain open until 12 September, enabling exhibitors and buyers from around the world to connect and conduct business discussions online during and beyond the physical fairs.Hong Kong Watch & Clock Fair marks 45th MilestoneHKTDC Associate Executive Director Smilely Lam said: “The Hong Kong Watch & Clock Fair and Salon de TIME together form the world's largest one-stop watch and clock marketplace. As the Hong Kong Watch & Clock Fair celebrates its 45th edition this year, the two fairs are continuing to grow in both international reach and diversity, leveraging Hong Kong’s strengths as an international trading hub and Asia’s premier sourcing centre for watches and clocks.This year’s fairs welcome, for the first time, a pavilion from Hengyang, Hunan Province, alongside group pavilions from France, Switzerland, Guangzhou and Taiwan. New exhibitors from Norway, Singapore and the US are joining this year's fair, further strengthening the international profile of the fairs.Salon de TIME is expected to feature more than 150 global brands, reaching a new post-pandemic high. Participation from Hong Kong brands and Guochao-inspired brands has increased by more than 20%, while more brands from Italy, the United Kingdom and the US are joining, alongside the debut of Singaporean brands. This fully demonstrates Hong Kong’s unique role as an important bridge connecting the Chinese Mainland with international markets, as well as the global watch industry’s confidence in the Hong Kong market.”According to the latest trade statistics, Hong Kong is the world’s largest importer and second largest exporter of wristwatches. In the first seven months of this year, the total export value of watches reached approximately HK$30.5 billion, representing a 7.8% year-on-year increase. Several other Hong Kong export markets recorded double-digit growth, including Germany (+21%), Switzerland (+25%) and the United Arab Emirates (+91%). In addition, the watch industry’s export confidence index rose from 50.4 to 51.9 in the second quarter, reflecting the industry’s cautiously optimistic outlook for exports.Microbrand participation doubles, bringing greater diversity to the fairLocated in Hall 3FG, Salon de TIME features six themed zones: World Brand Piazza, Chic & Trendy, Craft Treasure, Renaissance Moment, Wearable Tech, and Microbrands. The Microbrands zone has attracted 29 brands from eight countries and regions, with both the number of participating brands and the number of represented countries and regions doubling compared with last year.World Brand Piazza showcases prestigious international watch brandsFor the 16th consecutive year, the World Brand Piazza zone is organised in partnership with Prince Jewellery & Watch, featuring limited-edition and rare timepieces from some of the world’s most prestigious watch brands. This year, Prince Jewellery & Watch will showcase exceptional creations from six internationally renowned brands: Baume & Mercier, Corum, DeWitt, Franck Muller, Montblanc and Sarcar.World Brand Piazza will feature a selection of limited-edition and highly collectible timepieces. Among the highlights, Franck Muller will present a ladies’ watch created in collaboration with French street artist Jisbar, marking the second partnership between the two parties. The brand will also host a product introduction seminar on 2 September titled “Franck Muller 2026 WPHH Novelties ‘Vanguard Lady Crazy Hours Jisbar’”.Meanwhile, Sarcar has specially created a unique platinum version of its Medusa timepiece exclusively for the World Brand Piazza. The one-of-a-kind watch is set with 228 diamonds, complemented by red garnets and green agates, showcasing exceptional high jewellery craftsmanship. Two marquise-cut diamonds are used to represent Medusa’s eyes. At the same time, the signature snake-hair motif extends seamlessly from the dial to the case and lugs, all meticulously sculpted from solid gold, offering the charm of ancient Roman stone sculptures of beautiful women.The Renaissance Moment zone will also welcome the debut appearance of WOLF, the luxury watch storage box and winder brand from the United Kingdom. Built around the concept of preserving heritage, WOLF provides professional care solutions for high-end mechanical timepieces. On the opening day of the fair (1 September), the brand will unveil its latest innovation, The Rocket, the world's most compact travel watch winder, highlighting WOLF's commitment to innovative design and exceptional craftsmanship.Guochao timepieces showcase the strength of Chinese watchmakingDesigns incorporating traditional Chinese cultural elements have gained strong market appeal in recent years. This year, Salon de TIME will bring together five leading independent watchmakers from the Chinese Mainland, all of whom will attend the fair in person.The Académie Horlogère des Créateurs Indépendants (AHCI) which is widely regarded as one of the most prestigious independent watchmaking institutions, maintains exceptionally stringent membership requirements. Currently, only four AHCI members are from the Chinese Mainland, and this year's exhibition will feature three of them including Xushu Ma, who was the first watchmaker from the Chinese Mainland admitted to the association, as well as Zehua Tan and Lin Yong Hua. The opportunity to see such a distinguished line-up in one place is particularly rare.In addition, several Guochao-inspired brands and Chinese watchmakers will showcase their outstanding creations. Highlights include:Chinese watchmaker Qian Guobiao will present the limited-edition AB-05S “Skylight Sun”, restricted to just 18 pieces worldwide. The self-developed AB-05 manual-winding movement powers the timepiece. At the same time, its semi-skeletonized dial reveals the balance wheel and gear train, highlighting the watch's intricate mechanics and technical expertise.Shanghai Watch will present the ORIGINATE Collection A623 Revival Watch, a modern recreation of China’s first calendar watch, modelling after the original A623 timepiece worn for many years by Zhou Enlai, the first Premier of the People’s Republic of China. The brand will also unveil the Hong Kong Exclusive Edition featuring two interchangeable straps in grey and green, with colours inspired by the Zhongshan suits frequently worn by Premier Zhou, evoking a spirit and memory that transcend generations.Award-winning timepieces showcase innovation and craftsmanshipThis year’s fair brings together award-winning timepieces, highlighting the watch industry’s pursuit of technical excellence and design innovation. Highlights include:AGELOCER’s 29.51-Day MoonPhase Original Astronomer reimagines the traditional moon phase display by featuring an industry-first 28.5mm oversized moon phase aperture. Blending astronomical imagery with mechanical aesthetics, the timepiece has earned nine international design awards, including the German Design Award 2022, MUSE Design Awards Gold 2023, and European Design Award 2023.Making its debut at the exhibition, Singaporean brand Vario will present the Vario VERSA Reversible Dual Time Watch. With an innovative reversible case design, the watch features two independent dials, each showing a different time zone. Users can easily switch between the two displays, making it a practical companion for international travellers. The unique design earned the watch the 2025 iF Design Award.Collaborations, innovation and limited-edition collectibles cater to diverse market tastesThe fairs will also feature collaborative, limited-edition, and debut timepieces, showcasing different styles and innovations to meet evolving consumer preferences, including:LINK2CARE has partnered with Swiss watch brand MARVIN to launch a luxury smartwatch that integrates LINK2CARE’s patented leather strap with concealed medical-grade vital sensor. The watch provides comprehensive health monitoring capabilities, including real-time tracking of mental resilience and stress levels, with data displayed directly on the watch dial.This year’s two major overseas pavilions, the Swiss Independent Watchmakers Pavilion (SIWP) and France’s Francéclat, together with other European exhibitors, will bring together around 80 brands from across Europe. Among the highlights, Swiss watchmaker Pilo & Co Genève will showcase the Corleone Mini Collection, created to celebrate the brand’s 25th anniversary. Reimagining the iconic Corleone design as a refined ladies’ timepiece, the collection blends elegance with contemporary sophistication, with each colour variant limited to just 10 pieces worldwide.Several product zones showcase industry strength; Time Tunnel celebrates 45th editionThe Hong Kong Watch & Clock Fair, to be held in Hall 1, features seven dedicated product zones. Among them, Pageant of Eternity will showcase premium finished watches from Original Equipment Manufacturers (OEM) and Original Design Manufacturers (ODM). One example is Hong Kong exhibitor Time Grand Ltd, which has more than 20 years of experience in product development, engineering design, and manufacturing services for global watch brands. Through its network of partnerships with Swiss watchmaking companies, the firm offers one-stop watchmaking solutions, demonstrating the strength of Hong Kong’s watch industry in connecting international watchmaking markets. Other zones include Complete Watches, Clocks, Machinery & Equipment, Packaging & Display, Parts, Components & Accessories.To celebrate the 45th edition of the Hong Kong Watch & Clock Fair, organisers will present a special “Time Tunnel” exhibition, taking visitors on a journey through three key stages in the fair’s evolution since its debut in 1982. The exhibition will revisit the period from the 1980s to the 1990s, when the fair established itself as a major global sourcing platform for the watch and clock industry. It then traces the transformation of Hong Kong’s watch industry between 2000 and 2020, as the sector evolved from OEM manufacturing toward brand development, with the fair becoming an important platform for industry promotion, networking, and exchange.The final section covers the period from 2020 to the present, when the fair expanded beyond manufacturing, sourcing, and brand promotion. Through cross-sector collaboration and the integration of resources from different industries, it has evolved into a multifaceted platform that brings together craftsmanship, design, technology, lifestyle, culture and consumer engagement, reflecting the continuous transformation of both the watch industry and the fair itself.Experts to share insights on emerging global watch industry trendsMore than 40 events will take place throughout the fair, including forums, seminars, watch parades, and networking activities, giving industry professionals valuable insights into the latest market developments and business opportunities.On the opening day (1 September), the Hong Kong International Watch Forum will bring together leaders of watch industry associations from Chinese Mainland, Germany, France, Switzerland, Japan and Korea to share the latest trade statistics and industry trends in their respective markets. Speakers will also explore new opportunities arising from the convergence of traditional watchmaking craftsmanship and technological innovation.On the second day (2 September), the Asian Watch Conference will be held under the theme “Hong Kong as the hub of International Watch Trades”. Senior analysts from international research firm Euromonitor International (Hong Kong) will present the latest developments in the global watch market. Representatives from online watch resale platform Chrono24 will discuss how businesses can connect with global demand through digital channels. At the same time, speakers from Lazada HK will share insights on how to leverage e-commerce platforms to accelerate market expansion and reach new customer segments.The 43rd Hong Kong Watch & Clock Design Competition, jointly organised by the HKTDC, the Hong Kong Watch Manufacturers Association Limited, and the Federation of Hong Kong Watch Trades & Industries Limited, aims to promote watch design exchanges and nurture local talent.This year, the themes for the Open Group and Student Group are “Transcending Time” and “Contours of the Breeze” respectively. The competition will continue to feature The Made-to-sell Award, recognising student entries with outstanding commercial potential. The award presentation ceremony will be held on 5 September at the fair’s event stage, with celebrity Joey Thye attending as a guest.Public activities and lucky draws offer an exciting visitor experienceSalon de TIME will host a variety of special activities and luxury watch showcases open to the public. Among the highlights, renowned watch art specialist and collector Labeg will lead a workshop on 4 September, demonstrating how to craft wristwatches from corrugated cardboard.This year, the exhibition also introduces the “Time Arena” activity zone, combining sports and luxury watch elements to offer visitors a fresh and interactive experience. A key feature will be the “Watch2Care Smart x Lifestyle Experience Days”, taking place from 4 to 5 September, featuring a range of interactive activities. Visitors will also have the opportunity to try pickleball, one of the fastest-growing sports in recent years.Other highlights include yoga and body mobility sessions, watch parades, and product launch events. Memorigin will unveil the Verdant Resonance Tourbillon watch, and invite several celebrity guests to attend its activities, including celebrity Vic Teo, Hong Kong basketball star Wong Lut Yiu, and renowned face-changing performer Hathor Wai.A Lucky Draw will be held daily throughout the fair, offering visitors the chance to win premium watches sponsored by brands including Memorigin, SAGA, ELMER INGO, Allied Asia Enterprise (PVT) Limited, Alexus Christy, Claudia Koch and FOKSY.In addition, CENTRESTAGE, Hong Kong’s premier fashion event, will take place concurrently at the HKCEC from 2 to 5 September, bringing together fashion brands and designer collections from around the world. The co-location of the events will create strong synergies, allowing visitors to explore the latest collections from more than 400 watch and fashion brands under one roof.Photo download: https://bit.ly/4xqIloMThe 45th HKTDC Hong Kong Watch & Clock Fair and 14th Salon de TIME take place from 1 to 5 September at the Hong Kong Convention and Exhibition Centre. Introducing fair highlights at a press conference are Smilely Lam, HKTDC Associate Executive Director (fifth from the left), SK Chong (fourth from the right) and Frankie Lam (fourth from the left), Co-Chairmen, HKTDC Hong Kong Watch & Clock Fair Organising Committee 2026, and celebrity Joey Thye (fifth from the right).Celebrity Joey Thye to host exclusive watch unboxing session, showcasing eight timepieces.The World Brand Piazza, organised in partnership with Prince Jewellery & Watch for the 16th consecutive year, has long been one of the exhibition’s signature attractions and remains a favourite among watch collectors. This year, Prince Jewellery & Watch is presenting luxury creations from six internationally renowned watch brands, including the Vanguard Lady Crazy Hours Jisbar (left), a collaboration between Franck Muller and French street artist Jisbar, as well as a unique platinum version of the Medusa timepiece (right) created exclusively for the exhibition by Sarcar. Chinese watchmaker Qian Guobiao will present the limited-edition AB-05S “Skylight Sun”, restricted to just 18 pieces worldwide. The self-developed AB-05 manual-winding movement powers the timepiece. At the same time, its semi-skeletonized dial reveals the balance wheel and gear train, highlighting the watch's intricate mechanics and technical expertise.AGELOCER’s 29.51-Day MoonPhase Original Astronomer reimagines the traditional moon phase display by featuring an industry-first 28.5mm oversized moon phase aperture. Blending astronomical imagery with mechanical aesthetics, the timepiece has earned nine international design awards, including the German Design Award 2022, MUSE Design Awards Gold 2023, and European Design Award 2023.Vario VERSA Reversible Dual Time Watch’s innovative reversible case design, the watch features two independent dials, each showing a different time zone. Users can easily switch between the two displays, making it a practical companion for international travellers. The unique design earned the watch the 2025 iF Design Award.LINK2CARE has partnered with Swiss watch brand MARVIN to launch a luxury smartwatch that integrates LINK2CARE’s patented leather strap with concealed medical-grade biometric sensors. The watch provides comprehensive health monitoring capabilities, including real-time tracking of resilience and stress levels, with data displayed directly on the watch dial.Memorigin will unveil the “Verdant Resonance Tourbillon watch”, inspired by the refined lifestyle of ancient Chinese scholars, particularly the tradition of playing the zither while enjoying incense. It combines Chinese cultural aesthetics with contemporary haute horlogerie craftsmanship. The 43rd Hong Kong Watch & Clock Design Competition features two categories, the Open Group and the Student Group, with design themes of “Transcending Time” and “Contours of the Breeze” respectively. Award-winning and shortlisted entries will be exhibited throughout the fair, showcasing the creativity and design talent of Hong Kong’s emerging and established watch designers. Photo shows representatives of the watch and clock industry together with the competition judges.Websites:Hong Kong Watch & Clock Fair: https://www.hktdc.com/event/hkwatchfair/enSalon de TIME: https://www.hktdc.com/event/te/enMedia enquiriesPlease contact the HKTDC’s Communications & Public Affairs Department: Johnny TsuiTel: (852) 2584 4395Email : johnny.cy.tsui@hktdc.orgAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) celebrates its 60th anniversary this year. The HKTDC is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in the Chinese Mainland, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Spritzer Sparkling Invites Malaysians to ‘Reset Rasa’ This Merdeka, Rediscover the Flavours That Unite Us ACN Newswire

Spritzer Sparkling Invites Malaysians to ‘Reset Rasa’ This Merdeka, Rediscover the Flavours That Unite Us

Inspired by the foods that unite Malaysians across cultures and generations, Reset Rasa celebrates the joy of experiencing familiar favourites anewTAIPING, Malaysia, Aug 26, 2026 - (ACN Newswire via SeaPRwire.com) - Our shared love for food has always been at the heart of what makes Malaysia unique. Whether it is enjoying nasi lemak in the morning, or devouring piping hot satay, char kway teow, or roti canai at any time of the day, our favourite local dishes are more than just meals. They are part of our identity and a reflection of the diverse cultures that bring Malaysians together.This Merdeka and Hari Malaysia, Spritzer Sparkling invites Malaysians to take a fresh look at the local foods they know and love through its nationwide 'Reset Rasa' campaign. Inspired by Malaysia’s rich food culture, the campaign celebrates the traditional dishes that continue to unite Malaysians and encourages people to experience the familiar flavours that have shaped our food heritage in a whole new way. Spritzer Sparkling's 'Reset Rasa' campaign celebrates Malaysia's rich food heritage by pairing its naturally refreshing sparkling water with iconic local favourites such as nasi lemak, acting as a palate cleanser that helps Malaysians rediscover every layer of flavour, bite after bite.While these iconic dishes have remained favourites across generations, the foods we enjoy the most are often the ones we take for granted. When a favourite dish becomes an everyday staple, it is easy to overlook the flavours, textures and aromas that made us fall in love with it in the first place. Spritzer Sparkling reminds us that sometimes it is not the food that needs changing or reinventing, but the way we experience it.Through ‘Reset Rasa’, Spritzer Sparkling invites consumers to refresh their palates between bites, helping diners savour the distinct flavours and textures of each mouthful. At the heart of the campaign is nasi lemak, one of Malaysia's most beloved dishes and the hero food pairing for its enduring place in everyday Malaysian life.Spritzer Sparkling complements and enhances the overall dining experience through three key food-pairing benefits. Its carbonation helps Menyegar Deria by refreshing the senses and palate during meals. It supports Keaslian Dirasai, allowing diners to appreciate the authentic flavours of the food without an overpowering sweetness, and it helps Meningkat Rasa, enhancing the enjoyment of every bite through a refreshed palate. Together, these qualities make Spritzer Sparkling an ideal companion for enjoying Malaysia’s favourite foods.Shiao Chan, Head of Marketing at Spritzer said, "Food is one of the strongest connections Malaysians share, regardless of race, language or background. Many of our favourite dishes have become such a familiar part of our daily lives that we sometimes stop noticing what makes them so memorable. Through ‘Reset Rasa’, we want to encourage Malaysians to embark on this journey of rediscovery. Slow down, savour and take pride in the flavours of the iconic local foods they already know so well with a new sense of enjoyment. With zero sugar and no calories, Spritzer Sparkling Natural Mineral Water is the perfect dining companion that complements our local cuisine without overpowering it, making every bite more enjoyable."Celebrating Malaysia's Love for Local FoodBringing the campaign to life is Spritzer Sparkling's 'Reset Rasa' Merdeka commercial film, which captures the pride, nostalgia and everyday joy that Malaysians experience through their favourite local dishes. The campaign highlights how food continues to connect communities across generations and cultures, reminding us that some of our strongest national bonds are formed around the dining table. Watch the commercial film on Spritzer’s YouTube channel.A scene from Spritzer Sparkling's 'Reset Rasa' Merdeka commercial film, which encourages Malaysians to see everyday local favourites through a fresh lens with Spritzer Sparkling, the ideal companion for every Malaysian dining occasion.For more information on Spritzer Sparkling’s recipes and roadshow dates and venues, visit the campaign microsite at: https://www.spritzer.com.my/sparklingmerdeka2026.About SpritzerEstablished in 1989, Spritzer is Malaysia’s best-selling natural mineral water brand. Its natural mineral water is sourced from underground aquifers protected within 433 acres of tropical rainforest in Taiping, Perak, and naturally filtered through underground rock layers for more than 15 years, enriching it with naturally occurring minerals, including silica.Combining nature, innovation and smart manufacturing, Spritzer is committed to delivering trusted, quality beverages while advancing sustainable practices across its operations. Spritzer Natural Mineral Water is independently tested annually by SIRIM and confirmed free from microplastics.Today, Spritzer offers a diverse portfolio including Natural Mineral Water, Sparkling Natural Mineral Water, Distilled Drinking Water and Fruit Flavoured Beverages, catering to different lifestyles and occasions.Inspired by the wisdom of water and nature, Spritzer is guided by its purpose to create a healthier and more sustainable future for all, with a vision to be the leading force of joy and wellbeing.For more information, visit Spritzer’s official website at www.spritzer.com.myFor media inquiries please contact:Nadzwan TahirSenior Executive, Narro CommunicationsT: +6018 399 1646E: nadzwan@narrocomms.comWinnie ChinHead of Public Relations, Spritzer BhdT: +6019 553 2663E: winniecgl@spritzer.com.my Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
China Shengmu Returns to Profitability in 1H2026 with Revenue Up 7.1% and Profit Attributable to Owners Reaches RMB64.0 Million ACN Newswire

China Shengmu Returns to Profitability in 1H2026 with Revenue Up 7.1% and Profit Attributable to Owners Reaches RMB64.0 Million

Highlights(RMB thousand) Six months ended 30 JuneYear-on-Year(“YoY”) Change20262025Revenue1,546,1451,444,2747.1%Gross profit447,839364,86622.7%Profit/(loss) for the period19,454(45,601)N/AProfit/(loss) attributable to owners of the parent company64,007(48,322)N/ARaw milk sales volume (tons)424,902372,97313.9%Annualized milk yield permilkable cow (tons/year head)13.1412.27+7,1%Cost of sales per kilogram of milk (RMB/kg)2.582.89-10.7%HONG KONG, August 27, 2026 - (ACN Newswire via SeaPRwire.com) - China Shengmu Organic Milk Limited (“China Shengmu” or the “Group”) (Stock Code: 1432.HK), the organic raw milk producer in China, today announced its financial results for the six months ended June 30, 2026 (the “Period” or “1H 2026”).In the first half of 2026, as the raw milk industry continued to undergo supply-demand rebalancing and end-market demand remained under pressure, the Group adhered to its operating strategy of “production based on demand, controlling volume while improving quality, and prioritizing efficiency”. The Group continued to focus on improving milk yield, optimizing its herd structure, and enhancing cost efficiency. During the Period, the Group recorded sales revenue of RMB1,546.1 million, representing a year-on-year increase of 7.1%. Gross profit increased by 22.7% year-on-year to RMB447.8 million, with gross profit margin improving from 25.3% to 29.0%. Profit attributable to owners of the parent amounted to RMB64.0 million, compared with a loss of RMB48.3 million in the same period last year, marking a return to profitability.The Group’s annualized yield per milking cow further increased to 13.14 tons, representing a year-on-year increase of 7.1% and a new historical high. This drove raw milk sales volume to 424,902 tons in the first half of the year, representing a year-on-year increase of 13.9%. Premium raw milk accounted for 79.5% of total raw milk sales, while the Group continued to enrich its product portfolio with differentiated products, including organic raw milk, organic A2 raw milk, and DHA raw milk. Although the average selling price of raw milk decreased by 6.0% year-on-year during the Period, the Group benefited from higher milk yield, lower feed costs, and refined feeding management. The cost of milk production per kilogram decreased to RMB2.58, representing a year-on-year decrease of 10.7%. As the decline in unit cost exceeded the decline in average selling price, the Group effectively enhanced its earnings resilience amid the industry downturn.During the Period, the Group continued to optimize its herd structure. Total cattle inventory stood at 140,521 head, with milking cows accounting for 48.5%, representing an increase of 0.7 percentage points from the end of 2025. Adhering to its “production based on demand” approach, the Group focused on optimizing low-efficiency and high-parity cows, increasing the proportion of high-efficiency milking cows, and reasonably controlling the scale of replacement heifers.Benefiting from the recovery in beef cattle market prices, the Group further optimized the grading, pricing, and sales management of culled cattle. During the first half of the year, the Group’s feedlot cattle business recorded sales volume of 8,099 head and sales revenue of RMB42.9 million, while net gain surged by 275% to RMB11.0 million, further enhancing the value of the Group’s cattle business across the full life cycle.In terms of smart farming and sustainable development, the Group continued to integrate herd data, environmental monitoring, and equipment operations into its digital management systems. Through the use of tools including wearable collars, thermal imaging, and data analytics, the Group improved the efficiency of heat stress management, precision feeding, and herd health management, while steadily advancing the application of smart feeding systems, robotic milking systems, and electric equipment.Leveraging the resource advantages of the Ulan Buh Desert, the Group continued to enhance its organic circular agriculture system covering “planting–breeding–returning to farmland,” promote the use of high-quality domestically produced forage, and advance manure resource utilization, as well as water- and energy-saving initiatives, further strengthening the distinctive advantages of its desert organic milk source.Mr. ZHANG Jiawang, Chief Executive Officer and Executive Director of China Shengmu, said: “In the first half of 2026, amid continued supply-demand adjustment and the raw milk industry remaining at the bottom of its cycle, China Shengmu further improved the quality of its operations by continuously increasing milk yield, optimizing its herd structure, and reducing unit costs. Raw milk sales volume increased by 13.9% year-on-year, annualized yield per milking cow reached a new historical high, and the cost of milk production per kilogram decreased by 10.7% year-on-year, enabling the Company to return to profitability. Looking ahead, we will continue to prioritize efficiency and maintain prudent operations, consolidate our advantages in organic and differentiated milk sources, deepen collaboration with key customers and industry partners, and continuously enhance asset productivity and profitability.”Looking ahead to the second half of 2026, the Group expects the domestic raw milk industry to remain in a phase of supply-demand rebalancing and recovery from the bottom of the cycle. The Group will continue to adhere to its strategy of “production based on demand, controlling volume while improving quality, and prioritizing efficiency,” further improve herd quality and milk yield, strengthen its cost curve advantage, deepen customer and product collaboration for organic and differentiated raw milk products, and advance digitalization and green production. Following the mandatory cash offer proposed by China Modern Dairy becoming unconditional in all respects on July 20, 2026, the Group will proceed with subsequent industry collaboration in accordance with applicable laws and regulations. While maintaining the distinctive characteristics of its organic milk sources and operational continuity, the Group will prudently assess and unlock potential synergies in areas including centralized procurement, cost management, breeding, and digital management.China Shengmu Organic Milk LimitedChina Shengmu Organic Milk Limited (“China Shengmu” or the “Group”; stock code: 1432.HK) is an organic raw milk producer in China. The principal business of the Group is dairy farming, production and sales of high-end desert-based organic raw milk and quality non-organic raw milk. The Group focuses on the production and sales of desert-based organic milk, while satisfying the diversified needs of customers for quality raw milk and continues to develop a variety of functional raw milk to enrich the Company’s product combination and enhance its profitability. As of June 30, 2026, China Shengmu owns 34 daily farms, including 1 fattening cow farm. The Company had 140,521 cows in stock.For investor and media enquiry:Christensen China LimitedEmail: Shengmu@christensencomms.com Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Guoxia Technology’s Net Profit Surged Nearly Tenfold in First Half of 2026, Revenue Reached RMB1.427 Billion, Both Hitting Record Highs ACN Newswire

Guoxia Technology’s Net Profit Surged Nearly Tenfold in First Half of 2026, Revenue Reached RMB1.427 Billion, Both Hitting Record Highs

HONG KONG, August 25, 2026 - (ACN Newswire via SeaPRwire.com) - On August 20, 2026, Guoxia Technology Co., Ltd. ("Guoxia Technology" or "the Company", a leading global provider of “AI+” energy storage system solutions, is pleased to announce the interim results of the Company and its subsidiaries (collectively, “the Group”) for the six months ended June 30, 2026 (the "Reporting Period").In the first half of 2026, the global energy storage industry sustained strong growth and formally entered the TWh era. Rising renewable energy penetration, growing demand for grid flexibility, and large-scale development of AI computing infrastructure, coupled with improving economics of energy storage, have jointly driven the industry into a new phase of market-oriented, high-quality development. Seizing this opportunity, Guoxia Technology has adhered to its "AI+" energy storage platform-based strategy, evolving into an integrated energy ecosystem aggregation service provider and achieving a significant leap in business performance.During the Reporting Period, the Group recorded total revenue of RMB1.427 billion, representing a year-on-year increase of 106.5%. Of this, domestic revenue amounted to RMB1.14 billion, up 101.7% year-on-year, while overseas revenue reached RMB288 million, up 127.9% year-on-year. Profitability also performed strongly, with an overall gross profit margin of 19.2%, up 6.7 percentage points year-on-year, and net profit of RMB60.25 million, up 980.7% year-on-year. Profitability continued to strengthen, while the quality of operations improved steadily.Dual-Engine Growth Across Global Markets Drives Rapid Expansion in Delivery ScaleIn the domestic market, the Group continued to deepen strategic cooperation with the "Two Grid Companies and Two Construction Groups" as well as leading energy investment groups, steadily expanding its market share in large-scale standalone energy storage power stations. Domestic energy storage system shipments reached 3.7GWh, up 105.6% year-on-year. Leveraging its proprietary Xinghan vertical large language model and AI algorithm capabilities, the Group achieved intelligent upgrades in power generation, load, and electricity price forecasting, and completed integration with VPP and electricity pricing platforms. This supports autonomous strategy control of household energy systems and proactive safety O&M of the systems, significantly improving customers’ energy utilization efficiency and economic returns.In overseas markets, in the first half of 2026 the Group established subsidiaries in Hong Kong, Singapore, the UK, the Netherlands, etc., building localized operation networks and service teams to develop comprehensive local service capabilities. A strategic breakthrough was achieved in the UK market, where the Group successfully entered the government-level projects, with its product compliance and localized delivery capabilities validated and brand recognition further enhanced. In Africa, the Group continued to deepen its presence, with localized networks in core markets continuously improved, driving rapid growth in business scale and further consolidating the Company’s market position in the African residential energy storage sector. According to CIC, based on newly installed capacity and shipment volume of multi-purpose energy storage systems globally in 2025, the Group ranked ninth among global energy storage system suppliers and seventh among Chinese suppliers worldwide, and stands among the global frontrunners in the African residential energy storage sector, underscoring the effectiveness of the Group’s strategy as recognized by an authoritative industry institution.In terms of capacity layout, in the first half of the year the Group added two new production bases in Chengdu and Lianyungang. The Group simultaneously advanced the construction of intelligent production lines for utility-scale energy storage and the capacity expansion of residential energy storage lines, systematically implementing intelligent manufacturing upgrades across all bases, significantly enhancing its in-house manufacturing capabilities and continuously reducing its reliance on external OEMs. At the supply chain management level, the Group integrated global resources and implemented lean manufacturing, leveraging economies of scale in procurement to effectively control raw material costs, effectively mitigating the impact of price fluctuations on profitability and ensuring steady and sustainable profit levels.Integrated Technology, Product and Platform Capabilities Build Full-Stack "AI+" Energy Storage CompetitivenessAt the technology R&D level, during the Reporting Period the Group deployed its own computing infrastructure and operated its proprietary Xinghan vertical large language model locally, continuously iterating its AI algorithm capabilities and optimizing the Safe ESS and HANCHU iESS platforms, constantly improving the accuracy of power generation, load and electricity price forecasting, thereby enhancing system safety while effectively creating excess returns for customers.At the product innovation level, the Group focused on core technology breakthroughs such as EMS intelligent dispatching and 3S integrated inverters, and built a thermal runaway simulation laboratory to solidify its safety foundation. During the Reporting Period, it launched a brand-new 16kWh residential energy storage product series for overseas markets, featuring larger capacity and higher safety to meet diverse scenario needs in Europe, Africa and elsewhere, while advancing R&D of next-generation energy storage batteries and inverters. It has now formed a multi-tiered product matrix covering residential, commercial & industrial, and grid-side applications.At the digital energy platform level, leveraging the digital energy platform the Group enables open access to multiple brands and products, breaking down data silos and building high-quality datasets to support the continuous evolution of AI. Through its three-tier proactive safety prevention and control system, it has realized the evolution of capabilities from "passive response" to "proactive maintenance," and is committed to providing customers with comprehensive energy services covering the full lifecycle of assets.Outlook: Deepening Integrated Ecosystem Layout, Toward Becoming a Leader in Smart Energy InfrastructureLooking ahead to the second half of 2026, the Group will remain firmly committed to its “AI+” Energy Storage strategy, and continue to cultivate six key strategic areas: iterating AI algorithms and large model capabilities, accelerating the rollout of the new-generation energy storage product matrix, deepening cooperation with domestic core customers and expanding its share of large-scale standalone energy storage power stations, while also cultivating the European and African markets and promoting localized operations, building a virtual power plant control system based on the AI dispatching platform, and pioneering the "green power—energy storage—computing" synergy model to provide high-reliability, low-cost green energy support for global intelligent computing centers.The Group is committed to building an integrated ecosystem encompassing “AI + Energy Storage + Virtual Power Plants + Computing,” advancing the deep integration of energy storage technologies with the new-type power system, and becoming a leader in smart energy infrastructure, while creating sustainable and superior returns for shareholders and partners through a long-term value-oriented approach. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
China State Construction International Delivers Significant Results in Low-Carbon Construction ACN Newswire

China State Construction International Delivers Significant Results in Low-Carbon Construction

HONG KONG, August 26, 2026 - (ACN Newswire via SeaPRwire.com) - China State Construction International Holdings Limited (“China State Construction International” or the “Group”, stock code: 03311), a pioneer in construction industrialisation, has continued to deepen its deployment of technologies including Modular Integrated Construction (“MiC”), Multi-trade Integrated Mechanical, Electrical and Plumbing (“MiMEP”) and Building-integrated Photovoltaics (“BIPV”). As governments in different markets accelerate the development of green buildings, ultra-low energy buildings and new construction industrialisation, demand for efficient and low-carbon construction solutions continues to grow. These businesses have become an important pillar supporting the Group’s transformation towards smart construction.Policy Support and Market Demand Drive Green ConstructionThe construction industry is facing multiple requirements to improve energy efficiency, reduce carbon emissions and minimise construction waste. The Chinese Mainland’s 15th Five-Year Plan promotes coordinated progress in carbon reduction, pollution control, green expansion and economic growth, and proposes the wider adoption of green and low-carbon construction methods, as well as the scaled development of ultra-low-energy buildings and prefabricated buildings. Relevant action plans for the construction sector also encourage the advancement of building-integrated photovoltaics, greater use of renewable energy and stronger efforts to enhance building energy conservation and carbon reduction. Hong Kong’s Climate Action Plan 2050 promotes energy-saving green buildings and waste reduction, with the target of achieving carbon neutrality before 2050 while progressively reducing building energy consumption and reliance on landfills.The Group’s subsidiary, China State Construction Hailong, has continued to promote the scaled application of MiC technology. Data show that carbon emissions during the construction phase of concrete MiC and steel-structure MiC can be reduced by 66.78% and 49.61%, respectively. Compared with traditional construction methods, construction waste can be reduced by more than 75%, material wastage by more than 25%, site electricity consumption by 60% and water consumption by 66%. Over the past five years, the Group has supplied more than 129,155 MiC modules across 116 projects, fully demonstrating the replicability of its technological achievements and its capability for large-scale implementation.Benchmark Projects Demonstrate Technological AdvantagesIn Hong Kong, the Chinese Medicine Hospital of Hong Kong and the Government Chinese Medicines Testing Institute project is the city’s first permanent hospital to adopt MiC and MiMEP. The Group designed and produced more than 7,000 MiMEP prefabricated modules for the project, compressing the mechanical, electrical and plumbing construction cycle from the traditional two to three years to within six months, shortening the construction period by more than 75%. Compared with conventional construction methods, the project reduced carbon dioxide emissions by approximately 1,596 tonnes, representing a carbon reduction of 43%.In addition, the IL9088 New Central Harbourfront Development Project applies approximately 2,500 MiMEP modules. Through standardised and interchangeable design, the project enhances construction efficiency for a high-end commercial complex and provides flexibility for future tenant changes and spatial reconfiguration, thereby reducing repeated construction works and renovation waste.In Shenzhen, the Huazhang New Affordable Housing Project, a development in which the Group participated, successfully passed the 2025 ultra-low-energy building review and became the only residential development among Shenzhen’s first batch of pilot projects. The project comprises five residential towers and 6,028 concrete modules, integrating standardised, industrialised, digitalised, intelligent and green solutions. It was completed and delivered within 365 days, providing 2,740 units of government-subsidised rental housing.In Guangzhou, the Dachong Resettlement Housing Project in Nansha District became China’s first modular building project to receive a 6% floor area ratio incentive in 2025, reflecting the effective integration of the Group’s MiC technology with local policies and public housing needs.ESG Performance Continues to Receive Market RecognitionWith the practical application of low-carbon technologies and quantifiable results, the Group’s MSCI ESG rating was upgraded from BBB to A, representing a three-notch improvement within two years. The Group has also been selected as a constituent of the FTSE4Good Index Series for 10 consecutive years and included in S&P Global Sustainability Yearbook (China Edition) for four consecutive years, reflecting the capital markets’ recognition of the Group’s green transformation strategy and long-term sustainable development capabilities.China State Construction International will continue to leverage its integrated “Technology + Investment + Construction + Asset Operation” strategy, and capitalise on its technological strengths in MiC, MiMEP and BIPV. The Group will further expand the large-scale application of green construction solutions and explore green finance and green asset operation models, creating long-term value for shareholders, investors and society with both environmental benefits and financial returns. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More